Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3037756	s-immfix	— (—)	8647	14593	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Other systemic involvement of connective tissue (FG)

817

1884

4.46

315.11

1.5

1.8

—

All pneumoniae

2468

5229

3.15

307.65

2.0

1.6

—

2168

4061

3.20

307.65

2.0

1.5

—

All kidney diseases

2853

4795

4.13

307.65

1.7

—

Oral corticosteroids

2619

5149

3.06

307.65

1.5

1.8

—

Malaise and fatigue

1343

3266

3.33

307.65

1.6

—

L04AX Other immunosuppressants

1785

4571

4.08

307.65

3.0

1.4

—

Fever of other and unknown origin

1809

3554

4.59

307.65

2.2

1.6

—

All chronic kidney diseases

2409

3652

5.61

307.65

1.6

1.7

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

2432

5323

3.12

307.65

2.0

1.6

—

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma, including Hilmo

184

130.48

307.65

2.2

1.3

—

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

3405

4783

5.01

307.65

1.7

—

Implicit Sepsis

2199

4879

3.43

307.65

1.7

1.6

—

Osteopathies and chondropathies

1625

4879

3.15

307.65

2.0

1.6

—

Systemic connective tissue disorders

1138

3299

3.61

307.65

1.5

1.7

—

Multiple myeloma, including Hilmo

1044

331

72.05

307.65

4.9

1.2

—

Explicit Sepsis, including avohilmo

1536

3793

3.84

307.65

1.9

1.6

—

Other septicaemia

1320

3343

3.90

307.65

1.8

1.5

—

Liquid cancers

2188

2469

9.64

307.65

3.1

1.2

—

Multiple myeloma

716

206

94.14

307.65

5.3

1.2

—

Abnormal findings on examination of blood, without diagnosis

1552

4500

3.26

307.65

1.6

1.7

—

Renal failure

2392

4126

5.34

307.65

1.7

1.6

—

Polyarthropathies

1829

3486

3.47

307.65

1.6

1.8

—

Non-invasive ventilation

733

1149

5.75

307.65

1.7

2.1

—

Acute renal failure

1102

2070

5.81

307.65

1.8

1.6

—

Glomerular diseases

837

1571

5.81

307.65

1.7

1.6

—

Chronic kidney disease

1721

3073

5.89

307.65

1.5

—

Other bacterial diseases, including avohilmo

2665

4815

3.56

307.65

1.9

1.6

—

Heart failure, not strict

2335

4256

3.84

307.65

1.6

1.8

—

Erysipelas, including avohilmo

1745

4587

2.89

307.65

1.5

1.6

—

Liquid cancers, including Hilmo

2300

2749

8.26

307.65

3.0

1.2

—

Renal tubulo-interstitial diseases

2841

5042

4.30

307.65

1.7

—

ILD medications: immunosuppressive drugs

2224

3739

5.65

307.65

2.7

1.3

—

Implicit Sepsis, including avohilmo

2201

4967

3.26

307.65

1.7

—

Bacterial infection, other or unspecified, including avohilmo

2097

4268

4.22

307.65

2.0

1.5

—

Anaemias

579

185

20.87

307.65

1.9

1.2

—

Inflammatory bowel disease treatment related agents

2606

5175

2.86

307.65

1.5

1.8

—

Primary_lymphoid and hematopoietic malignant neoplasms

1969

2126

10.97

307.65

3.3

1.2

—

Dialysis, with operation codes

656

930

7.86

307.65

1.8

1.6

—

Aplastic and other anaemias

2080

4362

4.66

307.65

1.7

1.6

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

2168

4061

3.20

307.65

2.0

1.5

—

Implicit bacterial Sepsis

1625

3611

4.07

307.65

1.7

1.6

—

First line medication for Crohn's disease

2596

4084

3.51

307.65

2.0

1.3

—

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

2106

4765

3.06

307.65

1.7

—

Transplanted organ and tissue status

478

660

8.03

307.65

4.9

1.6

—

ILD medications: prednisolone, methylprednisolone, prednisone

2564

4219

3.46

307.65

1.6

1.3

—

Other septicaemia, including avohilmo

1333

3411

3.84

307.65

1.8

1.5

—

Explicit Sepsis

1524

3752

3.87

307.65

1.9

1.6

—

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

1201

327

93.19

307.65

2.2

1.2

—

Pneumonia, organism unspecified

2300

4981

3.25

307.65

2.0

1.6

—

Other bacterial diseases

2774

5052

3.76

307.65

1.9

1.6

—

Nephropathy related operations

607

1050

6.41

307.65

1.8

1.7

—

Septicaemia

1504

3603

3.99

307.65

1.9

1.5

—

Influenza and pneumonia

2465

5054

3.08

307.65

2.0

1.6

—

Second line medication for Crohn's disease

1808

4647

4.06

307.65

3.0

1.4

—

Pneumonias (Asthma/COPD co-morbidities)

2468

5204

3.18

307.65

2.0

1.6

—

Other anaemias

1970

4185

4.71

307.65

1.7

1.6

—

Multiple myeloma and malignant plasma cell neoplasms

1060

430

54.64

307.65

4.9

1.2

—

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

716

206

94.14

307.65

5.3

1.2

—

Other and unspecified anaemias

1964

4160

4.75

307.65

1.7

1.6

—

ILD medications

2818

4232

3.69

307.65

2.0

1.3

—

Condition for Implicit Sepsis (Organ dysfunction codes)

2150

4924

3.11

307.65

1.7

—

Bacterial Sepsis

1812

3839

4.11

307.65

1.8

1.6

—

Heart failure,strict

1596

3446

3.37

307.65

1.5

1.7

—

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

647

701

11.18

307.65

1.7

1.6

—

Implicit bacterial Sepsis, including avohilmo

1721

3801

3.96

307.65

1.7

1.6

—

Bacterial infection, other or unspecified

1990

4151

4.25

307.65

2.0

1.5

—

Glomerular disorders in diseases classified elsewhere

559

986

6.24

307.27

1.7

—

Oxycodone

1208

3165

3.39

305.23

2.6

1.5

—

Infections, IBD-co-morbidities

443

351

9.27

300.82

2.5

1.8

—

Non-Hodgkin lymphoma, all, including Hilmo

573

1063

5.86

297.50

1.5

1.2

—

General symptoms and signs

2015

3834

2.68

295.47

1.7

1.6

—

Heart failure, strict

1750

4595

2.74

290.34

1.5

1.7

—

Care involving dialysis

425

604

7.90

289.24

1.7

1.6

—

Gout

1008

2472

3.68

285.62

1.9

1.7

—

Malignant immunoproliferative diseases

195

45.34

284.70

2.1

1.8

—

Autoimmune diseases excluding thyroid diseases

2185

4862

2.48

282.45

1.5

1.8

—

All-cause Heart Failure

1717

4535

2.73

282.17

1.5

1.7

—

Acute tubulo-interstitial nephritis

1451

4365

2.88

280.36

1.5

1.7

—

Autoimmune diseases excluding thyroid diseases, strict definition

2115

4706

2.49

275.77

1.5

1.8

—

Erysipelas

1416

4352

2.89

275.47

1.5

—

Polyneuropathies and other disorders of the peripheral nervous system

840

2253

3.97

273.91

1.7

1.6

—

Heart failure and antihypertensive medication

716

988

4.92

268.71

1.5

2.2

—

Metabolic disorders

1968

4804

2.51

267.29

1.7

—

Unspecified kidney failure

508

937

5.94

266.05

1.8

1.5

—

Viral Sepsis

721

1779

4.27

262.81

1.8

1.5

—

Implicit viral Sepsis

719

1778

4.26

261.30

1.8

1.5

—

Other and unspecified polyneuropathies, also in other diseases

765

1998

4.10

259.52

1.6

—

Osteoporosis

929

2510

3.58

257.10

1.6

—

Implicit viral Sepsis, including avohilmo

919

2742

3.48

251.86

1.8

1.6

—

Persons encountering health services for specific procedures and health care

2107

5366

2.36

250.80

1.9

1.6

—

Other diseases of blood and blood-forming organs, wide

756

2008

3.98

249.26

1.9

1.7

—

Tramadol

1611

3699

2.67

248.50

1.8

1.5

—

Gout, FINNGEN

1008

3225

3.26

245.54

1.9

1.6

—

Other heart diseases

758

1198

4.19

240.60

1.8

2.0

—

Asthma, unspecified (mode), excluding more controls

1012

2250

3.29

235.58

1.5

1.6

—

Nutritional anaemias

1366

5042

2.66

232.45

1.5

1.6

—

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma

120

154.94

227.70

2.3

1.4

—

Dyspnoea

1971

6374

2.28

227.29

1.7

—

Any gastric operation

1192

1951

3.11

226.71

1.6

1.5

—

GASTRO-related operations

1192

1951

3.11

226.71

1.6

1.5

—

Other systemic involvement of connective tissue

838

2537

3.45

225.82

1.5

1.7

—

Iron deficiency anaemia

1197

4379

2.77

221.07

1.5

1.6

—

Certain infectious and parasitic diseases

1680

3402

2.51

218.28

1.7

1.5

—

Other disorders of fluid, electrolyte and acid-base balance

946

2945

3.14

216.64

1.5

1.6

—

Finngen Rheumatological endpoints

1697

4028

2.43

213.76

1.6

1.8

—

Malignant neoplasm

1593

3827

2.48

211.35

2.4

1.2

—

Asthma, unspecified (mode)

1060

2622

2.98

210.32

1.5

—

Malignant neoplasm

1590

3836

2.47

209.12

2.4

1.2

—

Glomerulonephritis

407

764

5.79

208.79

1.7

—

Covid-19 confirmed case

1063

3859

2.85

207.52

1.7

1.6

—

Other and unspecified iron deficiency

975

3378

2.99

207.33

1.5

1.6

—

Malignant neoplasm, including Hilmo

1590

3827

2.46

207.26

2.3

1.2

—

Autoimmune diseases related-to ILD

1742

6529

2.27

206.47

1.5

1.7

—

Diseases of arteries, arterioles and capillaries (FINNGEN)

559

847

4.71

206.42

1.6

1.9

—

Oedema, not elsewhere classified

841

2619

3.24

205.82

1.6

—

Malignant neoplasm, wide definition

1584

3861

2.43

200.76

2.3

1.2

—

L04AD Calcineurin inhibitors

388

721

5.77

200.53

2.1

1.7

—

L04AA Selective immunosuppressants

621

1682

3.86

198.25

1.5

1.7

—

Hypertensive diseases (excluding secondary)

759

1209

3.72

197.79

1.6

2.0

—

Amyloidosis

214

12.78

197.10

2.8

1.6

—

Amyloidosis, other/unspecified

194

169

15.29

196.90

2.9

1.6

—

Bacterial pneumoniae

1022

3231

2.86

196.43

1.8

1.5

—

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

1620

6307

2.29

196.18

1.7

—

Disorders of mineral metabolism

362

655

6.00

193.18

2.2

1.7

—

Dental caries

703

1963

3.50

192.78

2.4

1.5

—

Provisional assignment of new diseases of uncertain etiology

1225

4962

2.51

187.25

1.7

1.6

—

Codes for special purposes

1226

4968

2.51

187.19

1.7

1.6

—

Disorders of calcium metabolism

315

516

6.75

187.06

2.3

1.6

—

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

316

303

7.67

185.95

1.5

1.7

—

Bacterial pneumonia, not elsewhere classified

967

3081

2.84

183.31

1.8

1.5

—

Caries of dentine

635

1761

3.61

183.18

2.4

1.5

—

Other heart diseases, wide

1521

3969

2.35

182.56

1.7

1.8

—

Extracorporeal dialysis

305

503

6.79

180.56

1.7

—

Reimbursement for rheumatic diseases

1255

5277

2.42

177.62

1.3

1.8

—

COPD/asthma/ILD related infections

1768

4061

2.21

174.61

1.9

1.5

—

COPD/asthma related infections

1768

4061

2.21

174.61

1.9

1.5

—

Cardiovascular diseases (excluding rheumatic etc)

753

1284

3.40

172.62

1.6

1.9

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

1815

5488

2.12

171.96

2.2

1.5

—

Codeine

1560

3738

2.29

170.36

1.6

1.5

—

Abnormalities of breathing

1586

4084

2.25

170.02

1.7

—

Asthma (only as main-diagnosis), excluding more controls

1098

2287

2.69

169.07

1.4

1.6

—

Other arthritis (FG)

705

2289

3.17

168.25

1.5

1.8

—

Asthma, excluding more controls

1151

2287

2.62

164.34

1.5

1.6

—

Coagulation defects, purpura and other haemorrhagic conditions

568

1645

3.61

164.28

1.7

1.6

—

Bacterial pneumonia (organism specified)

1132

4260

2.47

164.11

1.8

1.6

—

Complications of surgical and medical care, not elsewhere classified

1952

6572

2.01

162.72

1.7

—

Neoplasms

1019

1957

2.76

162.26

1.8

1.2

—

Non-follicular lymphoma

403

936

4.68

161.10

1.4

1.7

—

Purpura and other haemorrhagic conditions

454

1146

4.19

161.04

1.7

1.6

—

Secondary hypertension

236

328

7.49

158.60

1.6

1.8

—

Enlarged lymph nodes

427

1037

4.29

158.56

1.5

1.7

—

Autoimmune diseases

1935

4875

2.04

157.12

1.6

1.8

—

Non-ischemic cardiomyopathy

882

2604

2.78

156.34

1.5

1.7

—

Hypertension, essential

1261

3017

2.40

154.89

1.6

2.0

—

Atrial fibrillation and flutter

561

986

3.76

153.70

1.8

2.0

—

Asthma

1243

2669

2.44

153.67

1.5

—

Valvular heart disease excluding rheumatic fever

1038

2977

2.55

152.90

1.6

1.8

—

Non-rheumatic valve diseases

1035

2972

2.55

151.83

1.6

1.8

—

Asthma (only as main-diagnosis)

1163

2669

2.47

151.81

1.4

1.5

—

Opioids

1564

3753

2.18

150.89

1.7

1.5

—

Type 2 diabetes, wide definition

1637

5005

2.10

150.52

1.4

1.9

—

Heart failure and bmi 25plus

960

2481

2.67

150.40

1.5

1.8

—

Other medical care

1170

4283

2.35

149.58

1.9

1.5

—

Cerebrovascular diseases (FINNGEN)

528

1014

3.73

147.58

1.5

2.0

—

Asthma (mode)

1218

2698

2.40

147.42

1.5

—

Streptococcal septicaemia, including avohilmo

326

685

5.07

146.48

2.1

1.6

—

Complications of medical and surgical care

1519

6726

2.07

144.23

1.8

1.7

—

Streptococcal septicaemia

319

667

5.10

144.20

2.2

1.6

—

Hypertensive diseases

1238

3027

2.34

144.19

1.6

1.9

—

Explicit bacterial Sepsis, including avohilmo

359

825

4.60

144.04

2.3

1.5

—

Other disorders of skin and subcutaneous tissue

1556

6507

2.06

143.96

1.6

1.7

—

Nephrotic syndrome

175

200

10.05

143.61

1.7

—

Used for control exclusion in common control thyroid runs

1787

4493

2.03

143.13

1.6

1.8

—

Hypertension

1235

3027

2.33

143.01

1.6

1.9

—

Non-Hodgkin lymphoma, all

221

332

7.41

142.98

1.5

1.2

—

Rheumatoid arthritis

751

2416

2.83

142.43

1.3

1.8

—

Other CVD (FINNGEN)

326

493

5.28

141.27

1.8

—

Osteoporosis with pathological fracture (FG)

296

597

5.37

140.21

1.4

1.7

—

Hypercalcemia

242

412

6.67

139.38

2.4

1.6

—

Explicit bacterial Sepsis

351

814

4.56

139.23

2.3

1.5

—

Cardiovascular diseases

628

1005

3.35

137.66

1.6

1.9

—

Spondylopathies

1556

4500

2.08

137.49

1.7

—

Low back pain

1418

4571

2.12

137.47

1.7

1.6

—

ILD medications: azathioprine

308

651

4.90

136.10

1.3

—

Pain in limb

1532

4786

2.06

135.67

1.7

—

Polymyalgia rheumatica

483

1434

3.57

135.59

1.4

1.6

—

Other specified/unspecified arthritis

624

2143

3.00

135.17

1.5

1.8

—

Atrial fibrillation and flutter with reimbursement

497

858

3.75

134.26

1.7

2.0

—

Codeine or tramadol medication

1997

5801

1.89

133.77

1.6

1.7

—

Heart failure and coronary heart disease

1142

3578

2.30

132.92

1.5

1.7

—

Hypertensive heart and/or renal disease

701

1816

2.91

132.82

1.3

1.8

—

All influenza

601

2046

3.02

132.20

2.6

1.5

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

597

1179

3.24

131.66

1.7

2.0

—

Other soft tissue disorders, not elsewhere classified

1667

4821

1.99

130.92

1.7

—

Disorders of lipoprotein metabolism and other lipidaemias

1539

4664

2.04

130.08

1.5

1.7

—

Any reimbursement code in KELA

635

991

3.25

129.92

1.7

1.3

—

Diseases of oesophagus, stomach and duodenum

1895

6011

1.88

127.81

1.7

—

Any event in cancer register

1485

4275

2.05

127.72

2.2

1.3

—

Gout, idiopatic and unspecified

761

3007

2.64

126.90

1.5

1.6

—

Gout, unspecified

640

2323

2.88

126.49

1.5

1.6

—

Abnormal findings on diagnostic imaging of lung

1189

5356

2.15

126.32

1.7

1.6

—

Insulin medication

1260

5040

2.11

125.21

1.5

1.8

—

Certain disorders involving the immune mechanism

492

1559

3.28

123.26

1.6

1.7

—

Acquired haemolytic anaemia

159

197

9.51

123.08

2.2

1.7

—

Chronic lymphocytic leukaemia, helper endpoint

165

214

8.80

122.24

1.4

1.2

—

Chronic lymphocytic leukaemia

165

214

8.80

122.24

1.4

1.2

—

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, including Hilmo

165

214

8.80

122.24

1.4

1.2

—

Seropositive rheumatoid arthritis

564

1933

2.99

121.40

1.3

1.8

—

Gout, strict definition

593

2115

2.94

121.39

1.5

1.6

—

Diabetic nephropathy, excluding more controls

466

1144

3.49

120.59

1.4

1.5

—

Pure hypercholesterolaemia

1429

4570

2.02

118.78

1.5

1.7

—

Hypothyroidism (congenital or acquired)

235

189

7.04

117.29

1.9

1.2

—

Bleeding

1649

6196

1.89

116.98

1.5

1.8

—

Other pulmonary diagnosis

1173

2696

2.21

115.88

1.8

1.5

—

Excluding asthma or asthma-COPD overlap

1172

2696

2.20

115.54

1.8

1.5

—

Secondary and unspecified malignant neoplasm of lymph nodes

273

603

4.81

115.48

1.3

1.2

—

Disorders of other endocrine glands

883

3807

2.33

115.30

1.7

—

Any death

1397

4989

2.00

115.01

1.8

1.7

—

Hypothyroidism and >3 levothyroxin purchases

231

188

6.97

114.40

1.9

1.2

—

Hypothyroidism, levothyroxine purchases

231

188

6.97

114.40

1.9

1.2

—

Cardiac arrhythmias

834

2187

2.48

114.16

1.8

2.0

—

Haemolytic anaemias

176

265

7.45

113.93

2.1

1.6

—

Thrombocytopenia, unspecified

275

621

4.76

113.69

1.6

—

Other disorders involving the immune mechanism, not elsewhere classified

155

204

8.52

113.03

1.7

—

Intestinal infectious diseases

1683

6852

1.85

112.50

2.0

1.6

—

Viral pneumonia

354

965

3.83

112.23

2.5

1.5

—

Certain infectious and parasitic diseases, including avohilmo

1107

2518

2.23

112.12

1.7

1.5

—

Asthma-related pneumonia

869

3828

2.32

111.83

1.5

1.6

—

Symptoms and signs involving the urinary system

1518

6097

1.91

111.48

1.6

1.7

—

COPD differential diagnosis

1160

2698

2.18

111.42

1.8

1.5

—

ILD differential diagnosis

1160

2698

2.18

111.40

1.8

1.5

—

Asthma-related pneumonia or sepsis

869

3834

2.31

111.40

1.5

1.6

—

Asthma, hospital admissions 3, pneumonia

869

3834

2.31

111.40

1.5

1.6

—

Myelodysplastic syndrome, including Hilmo

156

212

8.28

110.77

1.5

1.2

—

Asthma, hospital admission 2, infections

1150

5542

2.06

109.96

1.5

1.7

—

Asthma-related infections

1150

5542

2.06

109.96

1.5

1.7

—

Other necrotizing vasculopathies (FG)

225

443

5.48

109.53

1.3

1.8

—

Ulcer of lower limb, not elsewhere classified

468

1550

3.17

109.41

1.5

1.6

—

Kidney transplant status

197

344

6.21

109.36

1.4

1.8

—

Examination and observation for other reasons

999

2519

2.27

108.88

1.6

1.7

—

1973

5660

1.79

108.63

2.1

1.5

—

Other necrotizing vasculopathies

275

646

4.59

108.29

1.4

1.7

—

Other diseases of pleura

1107

4699

2.10

107.96

1.5

1.6

—

Care involving use of rehabilitation procedures

1155

5151

2.05

107.75

1.5

1.6

—

Diseases of arteries, arterioles and capillaries

1462

5705

1.91

107.48

1.5

1.7

—

Implicit fungal Sepsis, including avohilmo

249

542

4.90

107.45

1.7

1.5

—

Preparatory care for dialysis

205

382

5.97

107.03

1.4

1.7

—

Diverticular disease of intestine

1434

4701

1.93

104.67

1.6

1.7

—

Azathioprine

308

800

3.98

104.25

1.3

1.8

—

Pain, not elsewhere classified

525

1893

2.83

103.70

1.7

—

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1222

6202

1.96

102.73

1.7

—

Syncope and collapse

842

3126

2.29

102.51

1.5

1.6

—

Insulin, combination of fast acting with intermediate-acting or long-acting

1261

5981

1.94

101.49

1.5

1.7

—

Parasetamol

1006

2319

2.22

101.05

1.7

1.6

—

Diabetes, varying definitions

1652

5305

1.82

100.89

1.5

1.8

—

Other autoimmune haemolytic anaemias

108

106

13.00

100.80

1.8

1.7

—

Complications of procedures, not elsewhere classified

1472

6484

1.85

100.62

1.6

1.7

—

Diabetes mellitus

1656

5306

1.82

100.48

1.5

1.8

—

Lymphoid leukaemia

236

526

4.90

99.73

1.5

1.6

—

Secondary uncertain malignant neoplasm

361

1086

3.46

98.63

1.3

1.2

—

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

427

617

3.51

98.08

1.7

—

Hyperkalaemia

240

551

4.69

97.33

1.6

—

Diarrhoea and gastroenteritis of presumed infectious origin

1236

5801

1.93

97.25

2.0

1.6

—

Lower back pain or/and sciatica

1852

6707

1.73

96.84

1.7

—

Diffuse large B-cell lymphoma, helper endpoint

189

358

5.73

96.33

1.3

1.2

—

Diffuse large B-cell lymphoma

189

358

5.73

96.33

1.3

1.2

—

Diffuse large B-cell lymphoma, including Hilmo

189

358

5.73

96.33

1.3

1.2

—

Type 2 diabetes

1628

5277

1.81

96.02

1.4

1.8

—

Haemorrhage from respiratory passages

777

3064

2.29

95.82

1.4

1.7

—

Other diseases of intestines

1635

5095

1.81

95.71

1.7

—

Continuous positive airway pressure

381

976

3.34

95.13

1.6

2.0

—

Medical observation and evaluation for suspected diseases and conditions

1044

2542

2.12

94.84

1.7

—

Hypothyroidism, drug reimbursement

159

148

7.62

94.78

2.0

1.2

—

Marginal zone B-cell lymphoma, including Hilmo

101

12.29

94.49

1.3

—

Disorders of lens

1260

4102

1.93

92.84

1.7

—

Other and unspecified dermatitis

1016

5118

2.02

92.83

1.6

1.7

—

Rheumatoid arthritis, including avohilmo

806

3749

2.20

91.70

1.3

1.7

—

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

1569

5237

1.80

91.65

1.4

1.8

—

Dermatitis

1180

6135

1.91

91.43

1.6

1.7

—

ILD, hospital admission 2, with pulmonary infections

301

856

3.70

90.11

1.5

1.4

—

Diseases of the skin and subcutaneous tissue

1554

4343

1.81

89.98

1.6

1.7

—

Agranulocytosis

309

898

3.61

89.40

2.2

1.7

—

Rare circulating lymphoid malignancy, including Hilmo

122

159

8.44

89.38

2.1

1.2

—

Dipeptidyl peptidase 4 (DPP-4) inhibitors

1219

5123

1.90

89.10

1.5

1.8

—

Constipation

1631

6404

1.75

88.76

1.8

1.7

—

Fungal Sepsis

174

331

5.72

88.35

1.8

1.5

—

Cytomegalovirus infection, IBD co-morbidity

119

154

8.77

88.30

3.4

1.6

—

Cardiomyopathy in other diseases

24.78

88.09

3.2

1.3

—

Bronchitis

1847

6610

1.69

87.95

2.2

1.5

—

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

129

184

7.75

87.51

1.6

—

Hypo-osmolality and hyponatraemia

450

1630

2.83

87.46

1.5

1.6

—

Infections of the skin and subcutaneous tissue

1036

5269

1.96

87.40

1.8

1.7

—

Implicit fungal Sepsis

163

296

6.01

87.09

1.9

1.6

—

Fracture of lumbar spine and pelvis

586

2435

2.48

86.99

1.6

—

Other acute lower respiratory infections

1021

5006

1.97

86.79

2.1

1.6

—

Diseases of liver

739

3398

2.23

86.60

1.4

1.7

—

Genitourinary diseases

801

1777

2.29

86.34

1.6

1.8

—

Dorsalgia

1544

4626

1.79

86.28

1.8

1.6

—

Disorders of parathyroid gland

529

2084

2.59

86.24

1.6

—

Isolated proteinuria

130

191

7.57

85.99

1.7

1.8

—

Insulin, intermediate and long-acting

1102

5656

1.91

85.31

1.5

1.7

—

Depression medications

217

195

5.64

85.23

1.6

1.2

—

Asthma (diagnoses ohter than nonallergic)

1497

6988

1.75

84.95

1.5

1.7

—

Cytomegaloviral disease

119

162

8.28

84.48

3.4

1.6

—

Dialysis

149

256

6.32

84.24

1.5

1.6

—

Osteonecrosis

212

494

4.58

84.20

3.3

1.6

—

Cytomegaloviral disease, including avohilmo

119

163

8.21

83.99

3.4

1.6

—

Hard cardiovascular diseases

1422

4718

1.80

83.79

1.6

1.8

—

Other functional intestinal disorders

880

3952

2.06

83.34

1.6

1.7

—

Intestinal infectious diseases, including avohilmo, including avohilmo

1930

6556

1.65

83.18

2.0

1.6

—

COPD (mode)

610

2014

2.41

82.34

1.4

1.5

—

Other bacterial intestinal infections

446

1677

2.75

82.00

2.1

1.5

—

Other arrhythmias

977

3724

1.98

81.06

1.6

1.8

—

Nerve, nerve root and plexus disorders

1809

6595

1.66

80.84

1.6

1.7

—

STROKE

941

3176

2.02

80.55

1.6

1.9

—

Other special examinations and investigations of persons without complaint or reported diagnosis

1004

2542

2.02

80.37

1.7

—

Endocrine, nutritional and metabolic diseases

1001

2520

2.02

80.34

1.6

1.9

—

Pain in throat and chest

1258

4076

1.84

80.29

1.6

1.7

—

Diabetes, insulin treatment (Kela reimbursement)

1700

6053

1.69

80.13

1.4

1.8

—

Symptoms and signs involving cognition, perception, emotional state and behaviour

1622

6470

1.69

78.96

1.6

1.7

—

Other/unspecified cytomegaloviral diseases

105

134

8.95

78.94

3.6

1.7

—

ILD, hospital admissions 3, with pneumonia sepsis

268

772

3.66

78.88

1.4

1.5

—

Antihypertensive medication - note that there are other indications

605

1288

2.48

78.65

1.5

2.1

—

Enterocolitis due to Clostridium difficile

319

1025

3.26

78.60

2.2

1.5

—

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

361

1243

3.01

78.44

1.4

1.2

—

Disorders of gallbladder, biliary tract and pancreas

1717

6465

1.67

78.38

1.6

1.7

—

Symptoms and signs concerning food and fluid intake

263

747

3.65

78.21

1.4

1.6

—

Sulfasalazine

496

2004

2.52

78.13

1.4

1.8

—

Senile cataract

1180

3902

1.87

77.90

1.7

—

Diabetic nephropathy

468

1832

2.64

77.85

1.4

1.5

—

Spinal stenosis

1047

4101

1.91

77.50

1.5

1.7

—

Other disorders of urethra and urinary system

1241

4820

1.81

77.28

1.7

—

Fall on same level

1751

5645

1.67

77.18

1.6

1.8

—

Small fibre neuropathy

140

249

6.26

76.93

1.7

1.6

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

1662

6346

1.67

76.58

1.7

—

Coxarthrosis [arthrosis of hip](FG)

989

3543

1.95

76.51

1.5

1.8

—

Hypertensive Renal Disease

157

310

5.49

76.48

1.4

1.8

—

Volume depletion

281

854

3.44

75.79

1.3

1.6

—

Headache

884

3455

2.00

75.67

1.5

1.6

—

Other and unspecified diseases of blood and blood-forming organs

130

220

6.62

75.28

1.9

1.7

—

Ischemic heart diseases

1427

4934

1.74

75.17

1.6

1.8

—

Spondylopathies in diseases classified elsewhere

110

10.25

75.17

5.1

1.6

—

Type 2 diabetes, definitions combined

1523

5238

1.71

74.73

1.5

1.8

—

Bacterial intestinal infections, IBD co-morbidities

447

1766

2.61

74.43

2.1

1.6

—

Hypertensive Heart Disease

544

1738

2.43

74.09

1.3

1.8

—

Other specific joint derangements/joint disorders

1035

3416

1.91

74.04

1.6

1.8

—

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1093

6068

1.82

73.64

1.5

1.7

—

Type 2 diabetes, strict (exclude DM1)

1531

5296

1.70

73.58

1.5

1.8

—

Solid cancers, including Hilmo

1193

3844

1.83

73.50

1.7

1.2

—

Disorders of thyroid, IBD co-morbidities

219

357

4.26

73.13

1.7

1.8

—

Benign neoplasm of colon, rectum, anus and anal canal

1302

6412

1.74

73.02

1.5

1.7

—

Percutaneous Coronary Intervention

1376

4862

1.74

72.80

1.6

1.8

—

Acute myeloid leukaemia and myelodysplastic syndromes

108

156

7.67

72.51

1.4

1.2

—

Other disorders of white blood cells

187

446

4.49

72.22

1.6

—

Emergency coronary revascularization (for ACS)

1529

5532

1.69

72.15

1.6

1.8

—

Seronegative rheumatoid arthritis

264

796

3.44

71.86

1.4

1.9

—

Diabetes medication

1635

5818

1.66

71.63

1.4

1.8

—

Other bacterial intestinal infections, including avohilmo

503

2137

2.41

71.30

2.0

1.5

—

Use of hypnotics and sedatives

1735

6140

1.63

71.03

1.9

1.6

—

Donors of organs and tissues

12.81

71.02

12.1

1.5

—

Symptoms and signs involving the skin and subcutaneous tissue

1247

6873

1.73

70.34

1.8

1.7

—

Hernia of abdominal wall, postoperative

313

1046

3.03

70.23

1.5

1.6

—

Dermatitis and eczema

1814

6756

1.60

70.10

1.6

1.7

—

Injuries to the abdomen, lower back, lumbar spine and pelvis

811

4112

1.98

69.87

1.7

1.6

—

Coronary revascularization (ANGIO or CABG)

1364

4864

1.72

69.55

1.6

1.8

—

748

3720

2.02

69.25

1.7

—

Cardiomyopathy

375

1406

2.74

69.21

1.7

1.6

—

Hypokalaemia

299

995

3.11

69.14

1.4

1.7

—

Presence of other functional implants

1169

4544

1.79

68.95

1.6

1.5

—

Sicca syndrome [Sjögren]

224

626

3.75

68.90

1.5

1.6

—

Abnormal findings on examination of urine, without diagnosis

158

343

4.95

68.79

1.7

1.6

—

Immunodeficiency with predominantly antibody defects

108

165

7.20

68.77

1.8

1.6

—

Neurological diseases, wide definition

278

384

3.67

68.18

1.5

1.8

—

Symptoms and signs involving the circulatory and respiratory systems

1390

4087

1.72

67.53

1.6

1.7

—

Immunodeficiencies

156

340

4.90

67.46

1.8

1.6

—

Type 2 diabetes, definitions combined, including avohilmo

1494

5224

1.67

67.28

1.4

1.9

—

Chronic nephritic syndrome

142

288

5.33

67.10

1.6

1.7

—

Other dorsopathies, not elsewhere classified

1484

4627

1.68

66.97

1.7

1.6

—

Seropositive rheumatoid arthritis, wide

564

2586

2.24

66.88

1.3

1.7

—

Pneumonia due to other infectious organisms, not elsewhere classified

125

227

5.96

66.73

2.1

1.7

—

Other/unspecified seropositive rheumatoid arthritis

559

2559

2.24

66.55

1.3

1.7

—

Acute bronchitis

789

4009

1.96

66.49

2.1

1.5

—

Hyperlipidaemia, other/unspecified

787

3648

1.98

66.38

1.5

1.7

—

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

550

2506

2.25

66.26

1.3

1.7

—

Anaemia in chronic diseases classified elsewhere

110

179

6.82

66.10

1.3

1.6

—

Conduction disorders

590

2178

2.21

65.88

1.4

1.6

—

Solid cancers

1150

3815

1.78

65.87

1.7

1.2

—

Failure and rejection of transplanted organs and tissues

11.59

65.81

4.3

1.9

—

Vocal cord dysfunction

199

450

3.97

65.74

1.6

2.1

—

Gonarthrosis [arthrosis of knee](FG)

1166

3812

1.78

65.72

1.6

1.8

—

Exposure to unspecified factor

1634

6973

1.61

65.67

1.7

—

Other abnormalities of plasma proteins

108

9.11

65.57

2.1

1.7

—

Nausea and vomiting

543

2401

2.25

65.55

1.7

—

Other abnormal findings of blood chemistry

157

352

4.75

65.54

1.7

—

Other disorders of kidney and ureter

340

1254

2.82

65.36

1.4

1.7

—

AV-block

419

1437

2.56

65.14

1.5

—

Diseases of the musculoskeletal system and connective tissue

636

1446

2.23

64.87

1.7

—

Major coronary heart disease event

1444

5244

1.67

64.81

1.6

1.8

—

Diseases of the digestive system

928

5077

1.84

64.71

1.5

1.6

—

Unspecified haematuria

889

3900

1.89

64.57

1.6

—

Insulin, fast-acting

672

3330

2.05

64.56

1.5

1.6

—

Other diseases of blood and blood-forming organs

210

589

3.77

64.51

1.7

1.6

—

Other cataract

853

3353

1.92

64.30

1.7

—

Other diseases of urinary system

1582

5505

1.63

64.30

1.6

1.7

—

Postmenopausal osteoporosis with pathological fracture

222

652

3.63

63.87

1.4

1.6

—

Myelodysplastic syndrome

10.57

63.80

1.5

1.2

—

Peripheral artery disease

985

4346

1.82

63.52

1.4

1.6

—

Other disorders of skin and subcutaneous tissue, not elsewhere classified

346

1307

2.74

63.28

1.6

—

Osteopathy in diseases classified elsewhere

13.81

63.19

6.1

1.6

—

Other respiratory diseases principally affecting the interstitium

469

2046

2.37

63.11

1.6

—

Other (seronegative) rheumatoid arthritis, wide

422

1759

2.47

62.75

1.3

1.7

—

Renal tubulo-interstitial disorders in diseases classified elsewhere

12.41

62.47

2.5

2.0

—

Disorders resulting from impaired renal tubular function

141

303

5.05

62.39

1.4

1.7

—

Hyperparathyroidism

436

1829

2.43

62.25

1.5

1.6

—

Chronic lower respiratory diseases

1829

6210

1.56

62.08

1.5

1.8

—

Disorders of choroid and retina

1477

6435

1.62

62.04

1.6

1.7

—

Other diseases of pericardium

142

307

4.92

61.93

1.5

1.7

—

Venous thromboembolism

1064

5950

1.75

61.74

1.8

1.6

—

Intracranial trauma

780

2718

1.96

61.53

1.6

1.8

—

Gastrointestinal diseases

685

1647

2.10

60.91

1.7

1.6

—

Other intervertebral disc disorders

1281

4565

1.69

60.81

1.7

—

Diseases of the respiratory system

885

2340

1.91

60.81

1.7

1.6

—

Pneumocystosis, including avohilmo

105

179

6.72

60.78

2.5

1.7

—

Pneumocystosis

105

179

6.72

60.78

2.5

1.7

—

Undetermined asthma, excluding more controls

232

714

3.33

60.76

1.4

1.5

—

Viral infections characterized by skin and mucous membrane lesions

743

3893

1.94

60.62

2.1

1.6

—

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

1439

7008

1.61

60.08

1.9

1.7

—

Polyarthrosis

436

1684

2.39

59.34

1.4

1.9

—

Giant cell arteritis

164

415

4.28

58.93

1.4

1.6

—

Viral pneumonia (known virus, not influenza)

120

239

5.49

58.16

3.0

1.6

—

Other antidepressants

1634

5317

1.58

57.98

1.6

1.8

—

Other/unspecified dorsalgia

634

3163

2.01

57.56

1.9

1.6

—

Pain in joint

893

3010

1.84

57.37

1.7

—

Interstitial lung disease

405

1734

2.42

57.07

1.5

1.6

—

Interstitial lung disease endpoints

405

1734

2.42

57.07

1.5

1.6

—

ILD, hospital admissions

401

1710

2.43

57.04

1.5

1.6

—

Presence of cardiac and vascular implants and grafts

917

3793

1.81

56.97

1.4

1.5

—

IgA nephropathy (IgA glomerulonephritis)

158

6.67

56.93

1.3

1.6

—

Other interstitial pulmonary diseases

405

1738

2.41

56.77

1.5

1.6

—

Pleural effusion

401

1720

2.41

56.20

1.5

1.6

—

Iron deficiency anaemia secondary to blood loss (chronic)

374

1554

2.48

56.08

1.5

1.6

—

Disorders of continuity of bone

207

627

3.41

55.99

2.3

1.6

—

Atherosclerosis, excluding cerebral and coronary sclerosis

928

4155

1.79

55.95

1.3

1.6

—

Fracture of rib(s), sternum and thoracic spine

654

3384

1.97

55.93

1.7

1.6

—

Fibrosis and cirrhosis of liver

219

692

3.32

55.78

1.2

1.7

—

Insulin, fast-acting or short human

674

3529

1.94

55.32

1.5

1.6

—

General examination and investigation of persons without complaint and reported diagnosis

892

2538

1.84

55.20

1.7

—

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

356

1459

2.52

55.19

1.2

1.7

—

Other pleural conditions

288

1071

2.80

54.70

1.6

—

Other (not insulin) diabetes medications

1535

5783

1.57

54.56

1.4

1.8

—

Malignant neoplasm of skin, including Hilmo

865

3224

1.82

54.34

1.7

1.2

—

Injuries to the thorax

884

5060

1.77

54.27

1.7

1.6

—

Ischaemic heart disease, wide definition

1347

5189

1.62

54.08

1.6

1.8

—

Mycoses

533

2595

2.09

54.06

1.8

1.7

—

Later onset COPD, excluding more controls

453

1547

2.29

53.93

1.4

1.5

—

Other and unspecified disorders of white blood cells

137

323

4.54

53.87

1.4

1.7

—

Paroxysmal tachycardia

283

846

2.82

53.87

1.5

1.9

—

Zoster [herpes zoster]

423

1889

2.30

53.75

2.3

1.6

—

Other dialysis

115

237

5.28

53.54

1.5

1.7

—

Osteomyelitis

184

536

3.61

53.38

1.9

1.6

—

DVT of lower extremities and pulmonary embolism

846

4790

1.79

53.38

1.9

1.6

—

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

818

3041

1.84

53.24

1.7

1.2

—

Gastro-oesophageal reflux disease

1121

5756

1.66

53.18

1.8

1.7

—

Benign neoplasm: Colon

1092

6242

1.67

52.94

1.6

1.7

—

Idiopathic gout

266

967

2.88

52.88

1.3

1.7

—

Obesity due to excess calories

719

3903

1.87

52.68

1.4

1.8

—

Arthropathies

1171

3558

1.68

52.30

1.5

1.8

—

Other retinal disorders

1222

5780

1.63

52.26

1.5

1.7

—

Symptoms and signs involving the nervous and musculoskeletal systems

1011

6068

1.69

52.15

1.5

1.7

—

Other malignant neoplasms of skin (=non-melanoma skin cancer)

793

2958

1.85

52.13

1.7

1.2

—

Asthma, hospital admissions , main diagnosis only

1265

6944

1.60

51.95

1.4

1.7

—

Undetermined asthma

232

784

3.03

51.93

1.4

1.5

—

Coxarthrosis

880

3215

1.79

51.85

1.5

1.8

—

Malignant neoplasm of skin

830

3135

1.81

51.82

1.7

1.2

—

Methotrexate

255

913

2.86

51.56

1.4

1.8

—

GI-bleeding

684

3696

1.89

51.23

1.4

1.6

—

Persons encountering health services in other circumstances, wide

1774

6094

1.51

51.00

1.7

—

Marginal zone B-cell lymphoma

11.61

50.83

1.3

—

SLE (Finngen)

102

198

5.47

50.46

1.2

1.7

—

Benign neoplasms

1397

4847

1.58

50.29

1.7

—

Spondyloarthritis

330

1359

2.48

50.23

1.4

1.7

—

Other CVD

491

2390

2.11

50.20

1.7

1.5

—

Other diseases of the digestive system

679

3689

1.88

50.03

1.5

1.6

—

Malignant neoplasm of bone and articular cartilage of other and unspecified sites

19.24

50.00

4.5

1.4

—

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

1556

6579

1.53

49.91

1.9

1.6

—

Chronic ulcer of skin, not elsewhere classified

200

644

3.26

49.42

1.2

1.6

—

Malignant neoplasm of bone and articular cartilage

12.97

49.26

4.1

1.3

—

Cirrhosis of liver, NAS

173

512

3.58

49.24

1.2

1.7

—

Vasculitis limited to skin, not elsewhere classified

109

232

5.13

48.98

1.3

1.7

—

Basal cell carcinoma, including Hilmo

786

2976

1.81

48.86

1.7

1.2

—

Hernia

1454

6320

1.54

48.77

1.6

1.7

—

Other gastritis (incl. Duodenitis)

461

2217

2.13

48.52

1.5

1.6

—

Biological medication for rheuma

272

1038

2.67

48.50

1.4

1.7

—

Factors influencing health status and contact with health services

408

870

2.38

48.45

1.6

1.4

—

Other nutritional deficiencies

996

5526

1.66

48.26

1.4

1.8

—

Zoster [herpes zoster], including avohilmo

950

5526

1.68

48.13

1.9

1.6

—

Other and unspecified vasculitis limited to skin

100

201

5.45

48.06

1.3

1.7

—

Osteonecrosis due to drugs

135

6.87

48.00

4.9

1.8

—

Spondylosis

926

4295

1.70

47.95

1.5

1.7

—

Pulmonary heart disease, diseases of pulmonary circulation

660

3607

1.86

47.74

1.7

1.6

—

ILD, hospital admissions 1, main diag only

353

1541

2.37

47.71

1.6

—

Missing teeth due to accident, extraction or parodontitis

1132

6372

1.61

47.32

1.8

1.7

—

Persons encountering health services for examination and investigation

885

2542

1.76

47.10

1.6

1.7

—

Dizziness and giddiness

1230

6122

1.58

46.88

1.6

1.8

—

Other arthrosis

843

3262

1.75

46.77

1.6

1.8

—

Other and unspecified types of non-Hodgkin lymphoma, hilmo

144

392

3.93

46.65

1.6

1.7

—

Coronary atherosclerosis

1134

4465

1.62

46.40

1.5

1.8

—

Hypotension

441

2126

2.13

46.39

1.8

1.5

—

Other and unspecified immunodeficiencies with predominantly antibody defects

9.46

46.06

1.7

1.9

—

Cutaneous abscess, furuncle and carbuncle

434

2085

2.12

45.61

1.7

—

Benzodiazepine use

1547

7024

1.50

45.58

1.6

1.7

—

All influenza (not pneumonia)

251

951

2.70

45.49

2.5

1.5

—

Retention of urine

713

3238

1.81

45.48

1.5

1.6

—

Endocarditis

110

249

4.69

45.45

1.3

1.6

—

Major coronary heart disease event excluding revascularizations

1101

4538

1.62

45.42

1.5

1.7

—

Cough

646

3307

1.84

45.32

1.7

—

Operations 2 for CAVS

684

3695

1.82

45.26

1.4

1.5

—

Calcific aortic valvular stenosis, diagnosis (helper)

684

3695

1.82

45.26

1.4

1.5

—

Abnormal findings on diagnostic imaging of other body structures

306

1281

2.46

45.24

1.9

1.7

—

Calcific aortic valvular stenosis, operated

684

3698

1.82

45.14

1.4

1.5

—

Calcific aortic valvular stenosis

684

3698

1.82

45.14

1.4

1.5

—

Symptoms and signs involving the digestive system and abdomen

1481

4898

1.53

45.01

1.7

—

Protozoal diseases

113

265

4.62

45.01

2.5

1.7

—

Drug-induced osteoporosis with pathological fracture

155

6.12

44.74

1.4

1.8

—

Dorsopathies

1400

4629

1.54

44.73

1.7

1.6

—

Pain (limb, back, neck, head abdominally)

1035

3149

1.66

44.66

1.6

1.7

—

Calcific aortic valvular stenosis, including rheumatic fever

684

3706

1.81

44.64

1.4

1.5

—

Temporal arteritis

136

369

3.97

44.41

1.3

1.7

—

Mantle cell lymphoma, including Hilmo

8.72

44.30

1.3

1.2

—

Asthma/COPD (KELA code 203)

1401

6207

1.52

44.19

1.4

1.8

—

Injuries to the hip and thigh

916

5002

1.66

44.13

1.5

1.6

—

Obesity related asthma

588

3182

1.88

43.80

1.5

1.8

—

Candidiasis

273

1100

2.54

43.76

1.9

1.6

—

Sleep apnoea

1484

6287

1.50

43.48

1.6

1.8

—

Neurological diseases

1077

3340

1.63

43.46

1.6

1.8

—

Sequelae of external causes of morbidity and mortality

497

2557

1.98

43.37

1.6

1.7

—

Abnormal weight loss

231

866

2.77

43.23

1.5

1.6

—

Noninfective enteritis and colitis

723

4169

1.75

43.16

1.7

1.6

—

Basal cell carcinoma

743

2902

1.77

42.72

1.7

1.2

—

Protozoal diseases, including avohilmo

113

277

4.40

42.45

2.5

1.7

—

Early onset COPD, excluding more controls

325

1432

2.31

42.36

1.4

1.5

—

Idiopathic thrombocytopenic purpura

219

4.84

42.24

1.5

—

Pulmonary embolism

593

3259

1.85

42.21

1.7

1.6

—

Complications of internal orthopaedic prosthetic devices, implants and grafts

482

2480

1.99

42.20

1.4

1.6

—

Other viral diseases

389

1842

2.13

41.95

2.6

1.6

—

Obesity

914

5314

1.63

41.77

1.4

1.8

—

Abnormalities of heart beat

571

3007

1.86

41.73

1.6

1.7

—

Candidiasis, including avohilmo

491

2546

1.96

41.70

1.7

—

Gonarthrosis

974

3377

1.64

41.62

1.5

1.8

—

Falls/tendency to fall

1453

4865

1.51

41.59

1.6

1.8

—

Pulmonary heart disease

593

3275

1.84

41.56

1.7

1.6

—

Diabetic retinopathy, excluding more controls

492

1373

2.05

41.55

1.4

1.5

—

Biguanides

1468

5991

1.49

41.47

1.4

1.8

—

Obesity and other hyperalimentation

917

5342

1.63

41.32

1.4

1.8

—

Weight loss

240

939

2.64

41.20

1.5

1.6

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

1653

6054

1.46

41.16

1.7

—

Other specified/unspecified systemic involvement of connective tissue

139

400

3.63

41.10

1.4

1.8

—

Type 1 diabetes

366

1714

2.16

40.94

1.4

1.7

—

Concussion

629

2710

1.81

40.83

1.6

1.8

—

Cerebrovascular diseases

1317

6097

1.51

40.81

1.5

1.7

—

Amputation

261

1071

2.52

40.56

1.5

1.6

—

Isolated proteinuria with specified morphological lesion

8.44

40.43

1.7

1.8

—

Sciatica+with lumbago

775

4093

1.69

40.26

1.6

1.7

—

Pacemaker

779

4349

1.69

40.16

1.4

1.6

—

Cellulitis

399

1952

2.08

40.12

1.9

1.6

—

Arthrosis

1010

3454

1.62

40.04

1.5

1.8

—

Malignant neoplasm of bone and articular cartilage, including Hilmo

7.30

40.01

4.3

1.3

—

Spondylopathies (FG)

201

726

2.82

40.00

1.3

1.8

—

Disorders of eyelid, lacrimal system and orbit

1380

6854

1.49

39.89

1.8

1.7

—

Other skin changes

410

2033

2.06

39.89

1.9

1.6

—

Urinary track infection

673

1875

1.81

39.55

1.6

1.9

—

Asthma, including avohilmo

1736

6710

1.43

39.53

1.5

1.8

—

L01XX Other antineoplastic agents

173

586

3.11

39.45

2.8

1.6

—

Cholelithiasis, broad definition with cholecystitis

1376

6204

1.49

39.25

1.7

—

Acute sinusitis

713

3811

1.72

39.20

2.2

1.6

—

Giant cell arteritis with polymyalgia rheumatica

136

402

3.64

39.15

1.3

1.6

—

Nonhereditary hypogammaglobulinemia

8.48

39.14

1.8

—

Dysphagia

496

2642

1.91

39.03

1.5

1.6

—

COPD

868

4369

1.64

38.60

1.4

1.7

—

Malignant neoplasm of bone and articular cartilage of other and unspecified sites, including Hilmo

8.91

38.29

4.5

1.3

—

Systemic lupus erythematosus

102

250

4.31

38.09

1.2

1.7

—

Other diseases of liver

329

1529

2.20

37.94

1.5

1.7

—

Diseases of the eye and adnexa

913

2807

1.64

37.86

1.6

1.7

—

Primary hyperparathyroidism

252

1051

2.48

37.84

1.6

—

Exclusions for E4_PCOS_BROAD

280

1219

2.34

37.67

1.6

1.7

—

Sleep apnoea, including avohilmo

1505

6304

1.45

37.59

1.6

1.8

—

Gastroduodenal ulcer

528

2896

1.85

37.52

1.5

1.6

—

Other and unspecified acquired haemolytic anaemias

8.18

37.52

2.0

1.4

—

Other joint disorders

1065

3555

1.57

37.48

1.5

1.8

—

Other noninfective gastroenteritis and colitis

415

2113

1.99

37.21

1.7

—

Arthropathies in other diseases classified elsewhere

243

4.29

36.86

1.2

2.0

—

Other diseases of intestine

312

1440

2.22

36.70

1.6

1.7

—

Pneumococcal septicemia

246

4.26

36.35

2.1

1.7

—

Pneumonia derived septicemia

103

264

4.13

36.25

2.2

1.7

—

Unspecified acute lower respiratory infection

279

1236

2.30

36.20

2.1

1.5

—

Myocardial infarction

883

3880

1.61

36.03

1.5

1.8

—

Fracture of femur

573

2942

1.79

35.68

1.5

—

Hydronephrosis

219

878

2.56

35.63

1.5

1.6

—

Injuries to the head

1619

6810

1.42

35.46

1.6

1.7

—

Acute upper respiratory infections of multiple and unspecified sites

1097

5313

1.52

35.10

2.3

1.6

—

Non-allergic asthma (mode), excluding more controls

258

1107

2.34

35.06

1.4

1.5

—

Fentanyl

214

855

2.56

34.92

3.3

1.4

—

Eosinophilic disease (BM)

7.34

34.90

1.9

1.8

—

Chronic apical periodontitis

1613

6420

1.42

34.76

1.8

1.6

—

Pruritus

216

872

2.54

34.62

1.6

—

Convulsions, not elsewhere classified

307

1418

2.16

34.55

1.3

1.6

—

Other viral diseases, including avohilmo

451

2393

1.88

34.52

2.4

1.6

—

Periodontitis

1506

6772

1.43

34.44

1.8

1.7

—

Suppurative and necrotic conditions of lower respiratory tract

148

495

3.13

34.43

1.6

1.7

—

Other disorders of ear

1411

6362

1.44

34.41

1.7

—

Other disorders of lacrimal gland

614

3621

1.72

34.24

2.0

1.7

—

Peripheral artery operations in Hilmo

295

1373

2.21

34.11

1.5

1.6

—

Tumor necrosis factor alpha inhibitors

222

913

2.47

34.03

1.4

1.7

—

Acute upper respiratory infections

1563

6654

1.42

34.00

2.1

1.6

—

Other disorders of adrenal gland

115

332

3.62

33.96

1.6

—

Sequelae with surgical and medical care as external cause

395

2047

1.97

33.96

1.6

1.7

—

Chronic periodontitis, including avohilmo

1502

6779

1.42

33.88

1.8

1.7

—

Mantle cell lymphoma

9.61

33.85

1.1

1.2

—

Other symptoms and signs involving cognitive functions and awareness

869

4946

1.58

33.75

1.5

1.7

—

Adrenocortical insufficiency

102

274

3.92

33.61

1.6

1.7

—

Cholelithiasis

1296

6117

1.46

33.53

1.6

1.7

—

Soft tissue disorders

1368

4841

1.46

33.50

1.5

1.7

—

Discitis, unspecified

143

5.35

33.11

1.3

1.7

—

Kela reimbursement Agammaglobulinemia (D80-84)

10.61

33.02

2.2

1.7

—

Ascites

179

678

2.73

32.95

1.2

1.7

—

Pericarditis

233

4.14

32.83

1.4

1.5

—

Other chronic obstructive pulmonary disease

819

4266

1.59

32.75

1.4

1.7

—

SLE, strict definition

248

4.05

32.63

1.2

1.7

—

SLE, ICD10

248

4.05

32.63

1.2

1.7

—

Budesonide

204

824

2.52

32.55

1.8

—

Pyothorax

121

373

3.41

32.37

1.6

1.7

—

Diseases of the myoneural junction and muscle

256

1150

2.29

32.36

1.5

1.6

—

Hypothyroidism, strict autoimmune

970

4179

1.53

32.17

1.6

1.8

—

Type 1 diabetes, wide definition, subgroup 1

275

1272

2.19

31.92

1.5

1.7

—

Diseases of spleen

132

5.42

31.91

1.3

1.6

—

Angina pectoris

966

4222

1.53

31.84

1.5

1.8

—

Drug-induced neutropenia

166

617

2.79

31.78

1.8

1.7

—

Pneumonia due to Streptococcus pneumoniae

252

3.92

31.71

2.0

1.6

—

Other/unspecified rheumatoid arthritis

261

1194

2.25

31.61

1.3

1.6

—

Other and unspecified aplastic anaemias

7.62

31.59

1.4

1.8

—

Abdominal and pelvic pain

1392

4898

1.44

31.57

1.7

—

Decubitus ulcer and pressure area

168

634

2.76

31.28

1.4

1.5

—

Seropositive rheumatoid arthritis, strict definition

275

1292

2.18

31.04

1.3

1.7

—

Dental operations

982

3318

1.53

31.02

1.6

1.5

—

Gastric ulcer

357

1846

1.97

30.95

1.4

1.6

—

Diaphragmatic hernia

650

4005

1.65

30.76

1.6

—

Episodal and paroxysmal disorders

1481

5355

1.41

30.59

1.5

1.7

—

Viral hepatitis, IBD co-morbidity

120

5.26

30.51

1.3

1.7

—

Other metabolic disorders

200

826

2.47

30.48

2.5

1.7

—

Peripheral arterial reconstruction

387

2070

1.91

30.45

1.4

1.6

—

Organ-limited amyloidosis

10.43

30.33

1.7

1.2

—

Lumbar disc prolapse

893

4343

1.53

30.32

1.7

—

Fibromyalgia

143

503

2.90

30.09

1.9

1.8

—

Paralytic ileus and intestinal obstruction

463

2618

1.79

30.03

1.6

—

Unspecified nephritic syndrome

163

4.73

29.99

1.4

1.8

—

Hepatomegaly and splenomegaly, not elsewhere classified

7.60

29.96

1.4

1.6

—

Myeloproliferative diseases

191

783

2.52

29.94

1.6

—

Allergic asthma (mode), excluding more controls

227

971

2.30

29.88

1.4

1.5

—

Other neurological diseases

1202

6528

1.44

29.83

1.6

1.7

—

Persons encountering health services in other circumstances

595

3569

1.67

29.77

2.0

1.7

—

Pyogenic arthritis

137

477

2.96

29.53

1.8

1.9

—

Dermatitis due to substances taken internally

117

373

3.25

29.45

2.2

1.7

—

Disorders of lacrimal system

708

4421

1.59

29.39

1.9

1.7

—

Other disorders of bone

268

1277

2.13

29.01

3.0

1.6

—

Hypoparathyroidism

104

313

3.51

29.00

1.7

1.6

—

Cystitis

1197

4983

1.44

28.38

1.6

1.7

—

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

200

857

2.40

28.34

2.4

1.6

—

Postprocedural endocrine and metabolic disorders, not elsewhere classified

184

757

2.48

28.33

2.5

1.7

—

Other diseases of the respiratory system

411

2289

1.83

28.32

1.4

1.6

—

Other respiratory disorders and diseases

411

2289

1.83

28.32

1.4

1.6

—

Tubulo-interstitial nephritis, not specified as acute or chronic

136

483

2.90

28.28

1.6

1.5

—

Deforming dorsopathies

413

2299

1.82

28.23

1.6

1.7

—

Noninfectious colitis NAS

234

1071

2.23

28.20

1.8

1.6

—

Charcot foot

127

5.17

28.14

1.1

2.0

—

Systemic lupus erythematosus, unspecified

210

4.07

28.14

1.3

1.6

—

Other symptoms and signs involving the nervous and musculoskeletal systems

633

3957

1.62

28.13

1.5

1.7

—

Chronic gastritis

500

2949

1.72

28.10

1.5

1.6

—

Respiratory insufficiency

161

625

2.64

27.96

1.4

—

Other external causes of accidental injury

1044

3553

1.48

27.91

1.6

1.7

—

Myalgia

345

1824

1.92

27.84

1.7

1.8

—

Any mental disorder

1542

5637

1.38

27.71

1.6

1.8

—

Non-allergic asthma (mode)

258

1221

2.12

27.68

1.4

1.5

—

Other and unspecified nerve root and plexus disorders, also in other diseases

328

1712

1.95

27.60

1.6

1.7

—

Myeloid leukaemia

238

3.85

27.35

2.0

1.6

—

COPD-related respiratory insufficiency

271

1333

2.09

27.33

1.4

1.6

—

Other disorders of veins

637

3951

1.60

27.32

1.6

1.8

—

Unspecified fall

815

5323

1.52

27.30

1.6

—

Open wound of lower leg

269

1316

2.08

27.30

1.4

1.7

—

Other diseases of anus and rectum

506

3005

1.70

27.22

1.6

—

199

863

2.34

27.21

1.8

1.7

—

Visual disturbances and blindness

825

5507

1.51

27.20

1.7

—

DVT of lower extremities

340

1807

1.92

27.18

2.3

1.7

—

Amputation of toe

176

728

2.51

27.16

1.4

1.6

—

Supplementary factors related to causes of morbidity and mortality classified elsewhere

472

2763

1.73

27.16

1.6

1.7

—

Elevated blood glucose level

159

625

2.61

27.13

1.6

—

Myeloproliferative diseases (CML excluded)

173

710

2.52

27.12

1.7

1.6

—

Malignant neoplasm of urinary organs, including Hilmo

213

957

2.28

26.97

1.2

—

Disturbances of skin sensation

371

2029

1.85

26.92

1.7

—

Sleep disorders (combined)

1573

6062

1.36

26.68

1.5

1.7

—

Accidents

1036

3553

1.47

26.67

1.6

1.7

—

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

166

672

2.53

26.62

2.3

1.6

—

Adalimumab

146

555

2.68

26.55

1.4

1.7

—

COPD, hospital admissions 3, with asthma pneumonia sepsis

563

2963

1.65

26.55

1.4

1.6

—

Meniscus derangement

762

3291

1.55

26.55

1.8

—

Diseases of oral cavity, salivary glands and jaws

896

3086

1.51

26.22

1.7

1.5

—

Viral pneumonia (unknown virus, not influenza)

135

499

2.79

26.09

2.4

1.7

—

Abnormal serum enzyme levels

543

3218

1.65

26.02

1.4

1.6

—

Injuries to the shoulder and upper arm

1278

7149

1.39

25.93

1.7

—

Acute myeloid leukaemia, helper endpoint

6.62

25.78

1.4

1.2

—

Acute myeloid leukaemia

6.62

25.78

1.4

1.2

—

Acute myeloid leukaemia, including Hilmo

6.62

25.78

1.4

1.2

—

Urticaria and erythema

480

2862

1.69

25.75

1.8

1.7

—

Diabetic maculopathy, excluding more controls

195

861

2.32

25.74

1.4

1.7

—

Substance abuse, excluding more controls

789

4390

1.51

25.72

1.4

1.7

—

Diagnoses used for exclusion with ILD

455

2682

1.72

25.68

1.4

1.6

—

Myocardial infarction, strict

788

3702

1.52

25.56

1.5

1.8

—

Allergic asthma (mode)

227

1038

2.15

25.48

1.4

1.5

—

Shoulder lesions

1100

4639

1.43

25.46

1.6

1.8

—

Type of accident

439

2566

1.73

25.45

1.6

1.7

—

External causes of morbidity and mortality

804

2645

1.53

25.37

1.7

—

Viral and other specified intestinal infections

229

1054

2.14

25.31

1.5

1.4

—

Follow-up examination after treatment for conditions other than malignant neoplasms

541

2186

1.66

25.26

1.7

1.6

—

Myocardial infarction, without ST-elevation

781

4726

1.51

25.15

1.5

1.6

—

Abnormalities of gait and mobility

257

1279

2.06

25.11

1.4

1.6

—

Type 1 diabetes, wide definition

279

1421

1.98

25.11

1.5

1.7

—

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

251

1223

2.08

25.09

1.4

1.2

—

Other specified/unspecified necrotizing vasculopathies

5.60

25.08

1.3

2.0

—

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

183

797

2.35

24.99

1.2

—

Other or unspecified ileus, impaction or obstruction

334

1815

1.87

24.90

1.6

—

855

5214

1.48

24.87

1.3

1.7

—

Persons with potential health hazards related to communicable diseases

367

2029

1.81

24.83

1.8

1.6

—

Polyuria

410

2376

1.75

24.68

1.5

1.6

—

Adjustment and management of implanted device

352

1959

1.83

24.40

1.5

—

Benign neoplasm: Colon, unspecified

480

2920

1.67

24.15

1.6

—

Acute generalized exanthematous pustulosis

104

351

3.08

23.92

2.3

1.7

—

Other reaction to severe stress, and adjustment disorders

394

2270

1.75

23.88

2.1

1.7

—

Drug-induced adrenocortical insufficiency

133

4.66

23.83

1.8

1.7

—

Depression or dysthymia

953

3603

1.45

23.72

1.5

1.8

—

882

5319

1.45

23.63

1.3

1.7

—

Stroke, excluding SAH

1049

5397

1.42

23.54

1.5

1.7

—

Cardiomyopathies, Primary/intrinsic

204

952

2.19

23.54

1.4

1.6

—

Conductive and sensorineural hearing loss

1248

6061

1.38

23.54

1.7

—

Abnormality of white blood cells, not elsewhere classified

7.16

23.52

1.5

1.8

—

L04AC Interleukin inhibitors

110

387

2.92

23.33

1.3

1.8

—

Generalized skin eruption due to drugs and medicaments

305

3.21

23.17

2.4

1.7

—

Alcohol use disorder, Swedish definition

810

5051

1.47

23.13

1.3

1.7

—

Statin medication

771

2898

1.51

23.11

1.5

2.0

—

Fracture of shoulder and upper arm

580

3723

1.57

23.04

1.8

1.6

—

Other chronic obstructive pulmonary disease, including avohilmo

956

5552

1.43

22.94

1.3

1.7

—

Stroke, including SAH

1082

5592

1.40

22.85

1.5

1.7

—

Malignant neoplasm of urinary organs

177

791

2.29

22.80

1.2

—

COPD, hospital admission 2, with asthma infections

616

3451

1.56

22.78

1.4

1.6

—

Obesity, other/unspecified

415

2463

1.70

22.74

1.3

1.8

—

Infection of intervertebral disc (pyogenic)

118

4.88

22.72

1.3

1.6

—

Essential (haemorrhagic) thrombocythaemia

244

3.45

22.51

1.7

1.2

—

Polyarthritis, unspecified

244

3.45

22.50

1.4

2.0

—

Eosinophilia

119

4.78

22.40

1.9

—

Chronic tubulo-interstitial nephritis

260

3.36

22.34

1.4

1.5

—

Phlebitis and thrombophlebitis (not including DVT)

358

2055

1.77

22.29

2.0

1.7

—

Ischaemic Stroke, excluding all haemorrhages

993

5216

1.41

22.26

1.5

1.7

—

Hypocalcemia

204

3.75

22.18

2.4

1.7

—

Crystal arthropathies, rheuma endpoint

154

4.22

22.13

1.3

1.9

—

Rheumatism, unspecified

219

1077

2.07

22.04

1.6

1.8

—

791

4914

1.46

22.02

1.6

—

Other diseases of arteries and capillaries

180

823

2.24

22.00

1.5

1.6

—

Hepatic failure, not elsewhere classified

321

3.09

21.91

1.4

1.7

—

Viral and other specified intestinal infections, including avohilmo

293

1526

1.86

21.88

1.5

1.6

—

Nonalcoholic fatty liver disease

167

743

2.30

21.73

1.4

1.8

—

Sensorineural hearing loss

1206

5928

1.37

21.72

1.6

1.7

—

Squamous cell neoplasms and carcinomas of the skin

201

965

2.13

21.63

1.5

1.2

—

COPD related to multimorbidity

747

4322

1.48

21.59

1.4

1.6

—

Disorders of sclera, cornea, iris and ciliary body

781

5413

1.45

21.51

1.6

1.7

—

Cardiomyopathy (excluding other)

206

1001

2.10

21.44

1.4

1.6

—

Mood disorders, excluding more controls

1264

5508

1.36

21.38

1.5

1.8

—

Diabetic neuropathy

252

1316

1.96

21.29

1.4

—

Diseases of pulp and periapical tissues and dental caries

1012

3701

1.41

21.24

1.6

—

Folate deficiency anaemia

5.43

21.18

1.5

1.7

—

Oesophageal varices

349

2.95

21.16

1.2

1.8

—

Vascular disorders of the intestines

154

673

2.35

21.04

1.5

—

Other local infections of skin and subcutaneous tissue

177

819

2.21

20.95

2.0

1.7

—

Visual disturbances

733

5054

1.46

20.81

1.8

1.7

—

Other and unspecified local infections of skin and subcutaneous tissue

169

770

2.24

20.80

2.0

1.7

—

Intestinal stricture

536

3472

1.56

20.73

1.6

—

Other and unspecified drugs and medicaments

155

683

2.32

20.71

2.3

1.6

—

COPD, early/later onset

822

4847

1.44

20.65

1.4

1.6

—

COPD, hospital admissions

814

4811

1.44

20.62

1.4

1.6

—

Familial hypercholesterolemia

266

1433

1.89

20.58

1.4

1.6

—

Psychiatric diseases

1344

5051

1.34

20.43

1.6

1.8

—

Acute posthaemorrhagic anaemia

265

3.22

20.38

1.9

1.5

—

Malignant neoplasm of digestive organs, including Hilmo

606

2941

1.53

20.37

1.5

1.2

—

Other diseases of hard tissues of teeth

844

3042

1.45

20.37

1.7

1.5

—

Malignant neoplasm, without specification of site, including Hilmo

339

2.92

20.31

1.3

1.2

—

Other coagulation defects

130

535

2.49

20.26

1.7

1.6

—

Mycoses, including avohilmo

1255

7184

1.34

20.21

1.6

1.7

—

Other embolism and thrombosis

219

1114

2.00

20.13

1.8

1.7

—

Cardiomyopathy, other and unspecified

132

549

2.46

20.11

1.6

1.7

—

Any operation in hilmo

22.61

20.03

1.3

1.4

—

Skin changes due to chronic exposure to nonionizing radiation

754

4760

1.45

20.03

1.6

—

Alcoholic liver disease

191

929

2.10

19.96

1.2

1.7

—

Actinic keratosis

740

4682

1.45

19.96

1.6

—

Reactive arthropathies

131

545

2.45

19.89

1.5

1.9

—

Bronchiectasis

169

787

2.21

19.86

1.6

—

Misadventures to patients during surgical and medical care

235

1232

1.94

19.76

1.7

1.6

—

Chronic periodontitis, complicated

875

6128

1.40

19.65

1.7

—

Gonarthrosis,primary

1406

6482

1.32

19.50

1.6

1.7

—

Acute pancreatitis

318

1837

1.76

19.47

1.5

1.6

—

Dental caries, including avohilmo

1111

4182

1.37

19.46

1.6

—

Acute peritonitis

133

565

2.42

19.44

1.4

1.7

—

Need for other prophylactic measures

113

445

2.62

19.42

1.4

1.6

—

Other crystal arthropathies

170

3.81

19.31

1.3

1.8

—

Other infectious diseases, including avohilmo

171

808

2.17

19.29

2.1

1.6

—

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

437

2747

1.61

19.24

1.4

1.9

—

Glucagon-like peptide-1 (GLP-1) analogues

437

2747

1.61

19.24

1.4

1.9

—

Abnormal results of function studies

147

658

2.28

18.93

1.9

1.7

—

Valvular operations

225

1181

1.94

18.85

1.2

1.5

—

Sarcoidosis

211

1085

1.98

18.83

1.4

1.6

—

Rotator cuff syndrome

906

4504

1.39

18.78

1.6

1.8

—

Acute nephritic syndrome

141

4.03

18.69

1.6

1.7

—

Reactive arthropathies, FINNGEN

103

394

2.67

18.68

1.6

1.8

—

Other diseases of pancreas

159

741

2.20

18.62

1.7

—

Hodgkin lymphoma, hilmo

198

3.48

18.57

1.3

1.7

—

Diabetic retinopathy

626

2624

1.50

18.54

1.4

1.5

—

Other and unspecified myopathies

175

848

2.11

18.54

1.6

—

Injury, poisoning and certain other consequences of external causes

642

2159

1.50

18.51

1.7

1.6

—

Other symptoms and signs involving the circulatory and respiratory systems

113

455

2.54

18.47

2.1

1.7

—

Drug-induced cataract

180

3.62

18.42

2.2

1.6

—

Iridocyclitis

332

1973

1.70

18.33

1.6

1.7

—

Chronic pancreatitis

213

1112

1.95

18.23

1.6

1.7

—

Malignant neoplasm of kidney, except renal pelvis

156

728

2.19

18.18

1.2

—

Carpal tunnel syndrome

859

5389

1.39

18.15

1.7

1.8

—

Dermatopolymyositis (FG)

4.90

18.04

2.1

—

Mental and behavioural disorders due to psychoactive substance use

819

5401

1.40

18.02

1.4

1.7

—

Etanercept

102

397

2.63

17.91

1.4

1.7

—

Caries of dentine, including avohilmo

1152

4412

1.34

17.88

1.6

—

Other headache syndromes

522

3457

1.52

17.86

1.7

1.8

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

274

1532

1.78

17.83

1.3

1.8

—

Coxarthrosis, primary

1018

6307

1.35

17.74

1.5

1.7

—

Inflammatory bowel disease

403

2535

1.60

17.71

1.7

—

Persons encountering health services for specific procedures, not carried out

119

500

2.42

17.71

1.3

1.6

—

Herpesviral [herpes simplex] infections

175

861

2.07

17.69

1.9

1.6

—

Other diseases of lip and oral mucosa

599

4108

1.47

17.60

1.9

1.7

—

Polyarteritis nodosa and related conditions

4.79

17.58

1.2

1.7

—

Sub-endpoint used in defining T1D endpoints

388

2391

1.61

17.32

1.4

1.6

—

Amputation of foot

250

3.12

17.25

1.5

1.6

—

Other immunodeficiencies

5.88

17.22

1.6

2.0

—

ILD-related respiratory insufficiency

344

2.77

17.22

1.6

—

Stomatitis and related lesions

274

1574

1.76

17.13

1.8

1.7

—

Delirium, not induced by alcohol and other psychoactive substances

254

1429

1.81

17.08

1.4

1.6

—

Artificial joint re-operation

151

716

2.17

17.06

1.4

1.6

—

Congenital malformations, deformations and chromosomal abnormalities

648

4289

1.44

17.05

1.5

1.7

—

Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue

5.20

17.03

2.0

1.9

—

Rash and other nonspecific skin eruption

159

767

2.11

17.02

1.6

1.7

—

Varicose veins

926

5166

1.36

16.99

1.7

—

Open wound of head

820

5615

1.38

16.85

1.5

1.6

—

Diseases of pulp and periapical tissues, including avohilmo

1396

5604

1.29

16.83

1.7

1.6

—

Nonischemic cardiomyopathy

180

912

2.01

16.83

1.5

1.7

—

Pain in thoracic spine

205

1086

1.91

16.72

2.0

1.7

—

Drug-induced polyneuropathy

5.33

16.57

4.7

1.5

—

Cervical disc disorders

507

3409

1.50

16.51

1.7

—

Anxiety disorders, excluding more controls

1028

4929

1.34

16.45

1.9

1.8

—

Allergic purpura

183

3.40

16.44

1.3

1.7

—

Substance abuse

789

5331

1.38

16.43

1.4

1.7

—

In situ neoplasms

635

4464

1.44

16.43

1.8

1.6

—

Autoimmune hepatitis, wide definition

277

2.89

16.42

1.4

1.8

—

Other degenerative diseases of the nervous system

422

1970

1.58

16.42

1.5

1.7

—

Collapsed vertebra, not elsewhere classified

5.57

16.39

3.2

1.6

—

Selective serotonin reuptake inhibitors

1322

5319

1.30

16.34

1.5

1.8

—

Myocarditis

173

3.41

16.31

2.4

1.9

—

Degeneration of macula and posterior pole

867

4934

1.37

16.26

1.5

1.6

—

Disorders of synovium and tendon

695

4197

1.41

16.22

1.5

1.8

—

Polycythaemia vera

226

3.12

16.19

1.2

—

Non-selective monoamine reuptake inhibitors

545

3578

1.47

16.16

1.6

1.8

—

Spondylolisthesis/Spondylolysis

266

1543

1.75

16.13

1.7

—

Crohn disease

166

829

2.03

16.12

1.5

1.7

—

Acute pancreatitis (for exclusion)

318

1937

1.66

16.09

1.5

1.6

—

Artificial joint operation, meniscal resection

1357

6792

1.28

16.02

1.6

1.7

—

Lung cancer and mesothelioma

288

1443

1.71

15.93

1.5

—

Urticaria

344

2138

1.62

15.92

1.8

1.7

—

Acute and subacute iridocyclitis

273

1602

1.73

15.89

1.7

1.6

—

Disorders of the thyroid gland

1279

6451

1.29

15.87

1.6

1.7

—

Papulosquamous disorders

565

3913

1.46

15.85

1.5

1.7

—

Sequelae of cerebrovascular disease

650

3932

1.43

15.84

1.4

1.6

—

Traumatic subdural haemorrhage

243

1289

1.79

15.83

1.5

1.6

—

Injuries to the elbow and forearm

936

6019

1.34

15.75

1.6

1.7

—

Pain associated with micturition

189

997

1.93

15.72

1.6

—

Functional dyspepsia

366

2323

1.59

15.58

1.7

—

Recurrent aphthous stomatitis , including avohilmo

209

1143

1.85

15.51

1.7

1.6

—

Pyoderma gangrenosum

6.06

15.38

1.5

2.1

—

Irritable bowel syndrome

332

2065

1.62

15.36

1.7

—

Disorders of oesophagus in diseases classified elsewhere

187

3.32

15.34

1.8

1.7

—

Other symptoms and signs involving the digestive system and abdomen

242

1387

1.77

15.33

2.2

1.7

—

Cholecystitis

242

1389

1.77

15.32

1.5

1.6

—

Psoriasis vulgaris

268

1583

1.71

15.26

1.4

1.7

—

Anterior Iridocyclitis

287

1728

1.68

15.20

1.6

1.7

—

Other hammer toe(s) (acquired)

262

1395

1.73

15.19

1.5

1.8

—

Cyst of kidney

143

695

2.11

15.17

1.5

1.7

—

Other specified diseases with participation of lymphoreticular and reticulohistiocytic tissue

15.17

1.6

1.2

—

Poisoning by drugs, medicaments and biological substances

247

1427

1.75

15.15

1.4

1.7

—

Benign neoplasm of other and unspecified endocrine glands

209

1153

1.84

15.14

1.6

1.7

—

Diseases of salivary glands

443

2952

1.51

15.14

1.6

1.7

—

malignant neoplasm of male genital organs, including Hilmo

415

1610

1.56

15.05

1.6

1.2

—

Dermatopolymyositis

103

4.21

15.04

2.1

1.9

—

Polycystic kidney disease

174

3.35

14.97

1.3

1.7

—

Disorder of lipoprotein metabolism, unspecified

217

1216

1.81

14.94

1.5

1.6

—

Collagenous colitis

155

780

2.03

14.87

1.7

1.6

—

Injuries to the knee and lower leg

1575

6823

1.25

14.78

1.5

1.7

—

Leisure time condition

261

1547

1.71

14.69

1.4

1.6

—

Cystic kidney disease

223

3.02

14.68

1.3

1.7

—

Other inflammatory liver diseases

114

513

2.27

14.66

1.4

1.8

—

Disorders of skin appendages

583

4098

1.42

14.60

1.5

1.7

—

Poisoning by medicine

222

1258

1.78

14.59

1.4

1.7

—

Other and unspecified disorders of skin and subcutaneous tissue

116

528

2.25

14.53

1.9

1.6

—

Psoriasis

393

2577

1.54

14.53

1.4

1.7

—

Secondary right heart disease

404

2.46

14.53

1.4

1.6

—

Sequelae of other external causes

104

452

2.36

14.53

1.5

1.7

—

Other abnormal immunological findings in serum

101

4.11

14.48

1.5

1.8

—

Haemorrhage, not elsewhere classified

303

2.69

14.46

1.5

—

Cryoglobulinemia

46.28

14.42

1.8

1.4

—

Viral warts

133

639

2.11

14.42

1.5

1.7

—

Ankylosing spondylitis

123

575

2.17

14.33

1.3

1.8

—

Bullous disorders

118

545

2.23

14.31

1.5

1.6

—

Respiratory disorders in diseases classified elsewhere

112

3.99

14.26

1.5

1.6

—

Lichen simplex chronicus and prurigo

110

494

2.28

14.23

1.5

1.7

—

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

344

2132

1.58

14.21

1.8

1.2

—

Ulcerative colitis

305

1897

1.62

14.19

1.8

1.6

—

Psoriatic and enteropathic arthropathies

138

678

2.06

14.08

1.5

1.8

—

Mature T/NK-cell lymphomas, hilmo

118

3.89

14.04

1.4

1.7

—

Open wound of ankle and foot

154

789

1.98

14.02

1.4

1.7

—

Herpesviral [herpes simplex] infections, including avohilmo

290

1787

1.64

14.00

1.8

1.6

—

Diseases of peritoneum

169

895

1.92

14.00

1.4

1.6

—

Chronic sinusitis

552

3892

1.43

13.96

1.7

1.8

—

Localized swelling, mass and lump of skin and subcutaneous tissue

445

3021

1.49

13.93

1.8

1.6

—

Injuries to unspecified part of trunk, limb or body region

163

854

1.94

13.92

1.4

1.6

—

Benign neoplasm of other and ill-defined parts of digestive system

290

1794

1.64

13.91

1.5

1.7

—

Asthma and allergy, excluding more controls

391

2.39

13.88

1.5

1.4

—

Systemic sclerosis (FG)

147

3.46

13.86

1.3

2.0

—

Other disorders of the musculoskeletal system and connective tissue

238

1402

1.72

13.80

1.8

1.6

—

Polyarteritis nodosa

6.35

13.79

1.2

1.3

—

Gout due to impairment of renal function

106

4.08

13.79

1.3

1.6

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

1215

6266

1.27

13.77

1.6

1.7

—

Epilepsy

418

2800

1.50

13.74

1.4

1.7

—

Other infectious diseases

139

694

2.05

13.71

2.1

1.6

—

Benign neoplasm: Ascending colon

259

1565

1.68

13.71

1.4

1.7

—

Heart failure and hypertrophic cardiomyopathy

165

3.33

13.57

1.7

1.8

—

Secondary thrombocytopenia

4.13

13.52

2.1

1.6

—

Drug-induced systemic lupus erythematosus

6.23

13.49

1.2

2.0

—

Hypertrophic cardiomyopathy

381

2.44

13.47

1.7

—

Primary biliary cholangitis (PBC)

140

3.49

13.46

1.2

1.8

—

Intracranial injury

812

5710

1.33

13.40

1.6

1.7

—

Hypothyroidism, other/unspecified

1164

6016

1.28

13.38

1.6

1.7

—

Neuromuscular dysfunction of bladder

150

776

1.97

13.34

1.4

1.7

—

Thrombotic microangiopathy

6.44

13.34

2.1

1.3

—

Cystic kidney disease, including avohilmo

241

2.83

13.33

1.3

1.7

—

Problems related to lifestyle

131

646

2.05

13.27

1.5

1.7

—

Unspecified privation

161

855

1.91

13.22

1.8

1.6

—

Juvenile arthritis (FINNGEN)

136

3.44

13.18

1.5

1.9

—

Artrosis, including avohilmo

1065

4525

1.29

13.17

1.5

1.8

—

Ulcerative colitis, NAS

173

941

1.86

13.13

1.8

1.7

—

Insulin, fast-acting (human)

161

856

1.90

13.10

1.5

1.6

—

Hypopituitarism

440

2.29

13.09

1.6

—

Malnutrition

163

3.26

13.09

1.2

1.5

—

Extreme obesity with alveolar hypoventilation

344

2.49

13.00

1.3

1.7

—

Malignant neoplasm of endocrine gland, including Hilmo

104

474

2.23

12.95

1.9

1.2

—

5-aminosalicylic acid

211

1221

1.74

12.95

1.8

—

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

709

4802

1.35

12.89

1.4

1.8

—

Primary biliary cholangitis, wide definition

144

3.39

12.88

1.2

1.8

—

Other secondary gonarthrosis

100

452

2.27

12.82

1.3

1.8

—

Other pulmonary heart/vessel disease

100

453

2.28

12.80

1.4

1.6

—

Malignant neoplasm of prostate, including Hilmo

403

1583

1.52

12.80

1.6

1.2

—

Thyroiditis, ILD-related definition

138

704

1.99

12.73

1.6

—

Malignant neoplasm, without specification of site

230

2.82

12.72

1.3

1.2

—

Diseases of male genital organs

676

2481

1.38

12.72

1.5

1.7

—

Diseases of the ear and mastoid process

1410

5685

1.25

12.70

1.7

—

Hypersplenism

9.98

12.57

1.1

1.3

—

Mixed connective tissue disease

127

3.54

12.53

1.3

1.8

—

Fall involving bed

339

2.48

12.49

1.4

1.6

—

Hyperplasia of prostate

573

2306

1.41

12.48

1.6

1.7

—

Paracetamol or NSAID medication

169

446

1.92

12.46

1.6

—

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

438

3032

1.46

12.45

1.8

1.7

—

Orchitis and epididymitis

151

802

1.91

12.43

1.5

1.7

—

Gingivitis and periodontal diseases

1339

5553

1.25

12.38

1.6

—

Other and unspecified coagulation defects

333

2.46

12.36

1.8

1.7

—

Personality disorders, excluding more controls

225

1339

1.69

12.35

1.4

1.8

—

Unstable angina pectoris

601

3441

1.38

12.34

1.5

1.7

—

Malignant neoplasm of endocrine gland

401

2.31

12.32

1.8

1.2

—

Fracture of lower leg, including ankle

732

5419

1.33

12.29

1.5

1.8

—

Asthma and allergy

413

2.26

12.29

1.5

—

Mental and behavioural disorders due to alcohol

682

4846

1.35

12.28

1.3

1.7

—

Suicide or other Intentional self-harm

257

1590

1.63

12.28

1.3

1.7

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

274

1721

1.60

12.28

1.3

1.7

—

Follicular lymphoma, hilmo

424

2.29

12.22

1.2

1.6

—

Malignant neoplasm of other connective and soft tissue, including Hilmo

258

2.66

12.20

2.9

1.2

—

Soft tissue disorders related to use, overuse and pressure

392

2670

1.48

12.16

1.7

1.8

—

malignant neoplasm of male genital organs

394

1592

1.50

12.12

1.6

1.2

—

Inflammatory diseases of the central nervous system

124

622

2.03

12.08

1.5

1.7

—

Hypothyroidism, strict autoimmune, 3 medication purchases required

1083

5750

1.27

12.06

1.6

1.7

—

Other complications of surgical and medical care, not elsewhere classified

140

733

1.94

12.04

1.8

1.6

—

Other specified/unspecified inflammatory spondylopathies

242

2.70

12.04

1.4

1.7

—

Other diseases of oesophagus

161

884

1.85

11.98

1.5

1.6

—

Mood [affective] disorders

1299

6711

1.24

11.98

1.5

1.8

—

Malignant neoplasm of digestive organs

516

2814

1.41

11.97

1.5

1.2

—

Mood disorders

1302

6717

1.24

11.96

1.5

1.7

—

Substance use, excluding alcohol

220

1318

1.68

11.96

1.4

1.7

—

Vitamin B12 deficiency anaemia

178

1010

1.79

11.88

1.8

1.5

—

Other viral diseases, not elsewhere classified

206

1211

1.71

11.87

2.4

1.6

—

Conjunctivitis (acute, non atopic)

332

2188

1.52

11.82

2.3

1.6

—

Congenital malformations of the urinary system

378

2.32

11.77

1.3

1.6

—

Lesion of ulnar nerve

194

1130

1.74

11.77

1.4

1.7

—

Cardiodefibrillation

605

4462

1.36

11.77

1.5

1.6

—

Diseases of external ear

495

3542

1.41

11.74

1.7

1.6

—

Migraine without aura

155

843

1.85

11.74

1.9

1.8

—

Acute bronchiolitis

126

3.26

11.66

3.5

1.4

—

Other anxiety disorders

440

2614

1.44

11.62

1.6

1.7

—

Hallux valgus (acquired)

402

1965

1.47

11.62

1.8

1.9

—

Other disorders of nervous system

117

585

2.04

11.58

1.8

1.7

—

Subjective visual disturbances

349

2347

1.50

11.57

2.1

1.7

—

Other disorders of bladder

202

1198

1.71

11.54

1.4

1.6

—

Other juvenile arthritis

123

3.39

11.53

1.6

1.8

—

Other abnormal uterine and vaginal bleeding

284

1298

1.59

11.51

1.8

—

Amputation of ankle bones

193

2.92

11.47

1.6

—

Organic, including symptomatic, mental disorders

892

4894

1.29

11.28

1.4

1.6

—

Symptoms and signs involving speech and voice

477

3419

1.41

11.25

1.6

1.7

—

Superficial injury of lower leg

323

2152

1.51

11.20

1.5

1.7

—

Malignant neoplasm of prostate

389

1568

1.48

11.14

1.6

1.2

—

Guillain-Barre syndrome

117

3.49

11.14

2.1

1.4

—

Fissure and fistula of anal and rectal regions

303

1996

1.53

11.10

1.7

—

Haemorrhoids and perianal venous thrombosis

478

3409

1.40

11.09

1.8

1.7

—

Primary gonarthrosis, bilateral

822

5340

1.30

11.09

1.5

1.7

—

Short Achilles tendon (acquired)

191

2.86

11.03

1.4

1.7

—

Asthma and opportunity respiratory infection

462

2.16

11.03

1.4

1.7

—

Unspecified urinary incontinence

145

792

1.86

11.03

1.3

1.6

—

Disorders of myoneural junction and muscle in diseases classified elsewhere

4.62

11.01

1.5

1.8

—

Late syphilis

3.72

10.94

1.1

1.7

—

Exclusions for E4_PCOS_CONSORTIUM

759

3618

1.31

10.93

1.7

—

Other and unspecified urticaria

219

1343

1.65

10.93

1.5

1.7

—

Malignant neoplasm of thyroid gland, including Hilmo

416

2.20

10.91

2.0

1.2

—

Shock, not elsewhere classified

4.65

10.90

2.5

1.8

—

Depression

1170

6313

1.24

10.87

1.5

1.8

—

Nonsuppurative otitis media

209

1093

1.67

10.86

1.6

—

Cholangitis (primary sclerosing, PSC)

103

504

2.08

10.83

1.3

1.6

—

Acute gastritis

121

627

1.97

10.82

1.7

1.6

—

Other diseases of upper respiratory tract

1467

6293

1.22

10.79

1.6

1.7

—

Dermatophytosis

210

1281

1.66

10.78

1.6

1.7

—

Somatoform disorder

193

1151

1.69

10.75

1.8

1.7

—

Intestinal malabsorption

362

2.29

10.73

1.4

1.6

—

Congenital malformations of the urinary system, including avohilmo

426

2.18

10.73

1.3

1.7

—

Viral warts, including avohilmo

240

1512

1.60

10.72

1.7

—

Malignant neoplasm of thyroid gland

374

2.26

10.72

1.8

1.2

—

Cardiac arrest

313

2.28

10.72

1.4

1.8

—

Disorders of muscles

143

784

1.85

10.71

1.5

1.7

—

Emphysema

138

750

1.88

10.71

1.6

1.7

—

Other nonthrombocytopenic purpura

4.23

10.71

1.6

1.7

—

Fracture of forearm

709

4874

1.31

10.67

1.6

1.7

—

Dermatopolymyositis, unspecified

5.91

10.64

1.5

1.9

—

Early onset COPD

325

2195

1.50

10.64

1.4

1.7

—

Systemic sclerosis

173

2.93

10.63

1.3

1.7

—

Drug-induced osteoporosis

116

3.46

10.63

1.3

1.8

—

Gingival hyperplasia

271

2.50

10.61

1.3

1.8

—

Disorders of conjunctiva

1012

6259

1.26

10.61

1.8

1.7

—

Lung diseases due to external agents

237

1496

1.61

10.61

1.4

1.6

—

IBD patients in KELA-register

246

1563

1.59

10.61

1.8

1.7

—

Calcinosis cutis

18.06

10.57

1.6

1.0

—

Cardiac murmurs and other cardiac sounds

105

515

2.04

10.53

1.7

1.6

—

Other peripheral vascular diseases

122

640

1.94

10.52

1.4

1.6

—

Vitreous haemorrhage

162

930

1.77

10.46

1.7

1.6

—

Other condition

185

1101

1.70

10.42

1.8

1.6

—

Ankylosing spondylitis, ICD10

115

593

1.97

10.42

1.3

1.8

—

Postprocedural musculoskeletal disorders, not elsewhere classified

129

693

1.90

10.41

1.9

1.6

—

Mental and behavioural disorders due to alcohol, excluding acute intoxication

588

4373

1.34

10.37

1.3

1.7

—

Other symptoms and signs involving the urinary system

167

970

1.75

10.34

1.4

1.6

—

Secondary systemic amyloidosis

10.34

10.32

2.2

1.2

—

Malignant neoplasm of other connective and soft tissue

154

3.01

10.30

3.6

1.3

—

Other renal tubulo-interstitial diseases

138

3.13

10.30

1.1

1.6

—

Transient ischemic attack

834

5212

1.28

10.28

1.5

1.7

—

Diabetic retinopathy, strict definition

277

1615

1.54

10.27

1.4

—

Other bacterial agents as the cause of diseases classified to other chapters

3.98

10.24

2.3

1.7

—

Infections with a predominantly sexual mode of transmission

249

1595

1.57

10.23

1.7

—

Chronic hepatitis, not elsewhere classified

264

2.49

10.21

1.4

1.8

—

Hernia of abdominal wall

651

4974

1.32

10.16

1.5

1.7

—

Idiopathic pulmonary fibrosis

151

859

1.79

10.14

1.4

1.5

—

Primary coxarthrosis, bilateral

482

3529

1.38

10.11

1.4

1.7

—

Anxiety (asthma-related co-morbidities)

608

3476

1.33

10.11

1.6

1.8

—

Sequelae of injuries of neck and trunk

212

2.67

10.10

1.9

1.8

—

Cerebral palsy and other paralytic syndromes

153

873

1.78

10.07

1.6

—

Neurotic, stress-related and somatoform disorders

1038

5750

1.25

10.05

1.8

1.7

—

Late syphilis, including avohilmo

125

3.26

10.05

1.2

1.7

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly, including avohilmo

194

1145

1.66

10.03

1.3

1.7

—

Other and unspecified haemorrhagic conditions

110

3.41

10.00

1.7

1.6

—

Other viral diseases, not elsewhere classified, including avohilmo

259

1678

1.54

9.96

2.2

1.6

—

Primary Sclerosing Cholangitis, IBD and UDCA required

115

3.31

9.95

1.7

—

Cushing syndrome

3.96

9.94

1.3

1.7

—

Coeliac disease

152

869

1.77

9.93

1.9

1.6

—

Corns and callosities

107

549

1.99

9.90

2.5

1.7

—

Other obstructive and reflux uropathy

237

2.54

9.90

1.4

1.6

—

Ventral hernia

349

2425

1.45

9.89

1.6

1.7

—

Anosmia

4.66

9.86

2.4

1.2

—

Clear cell adenocarcinoma of kidney

318

2.31

9.84

1.2

—

Anxiety disorders

1052

5828

1.24

9.82

1.8

1.7

—

Carrier of infectious disease

153

2.96

9.81

1.1

1.7

—

Other localized connective tissue disorders

165

2.90

9.76

1.6

1.7

—

Adverse effects, not elsewhere classified

211

1323

1.61

9.68

2.0

1.7

—

Inflammatory bowel disease, strict (require KELA)

246

1598

1.55

9.67

1.8

1.7

—

Other/unspecified reactive arthropathies

485

2.04

9.66

1.6

—

Bipolar affective disorders

175

1047

1.68

9.66

1.3

1.7

—

Leukaemia of unspecified cell type

3.91

9.64

2.4

1.8

—

Other diseases of stomach and duodenum

109

569

1.95

9.61

1.5

1.6

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

180

1053

1.67

9.60

1.3

1.7

—

Disorders of adult personality and behaviour

247

1609

1.54

9.57

1.4

1.7

—

Benign neoplasm: Sigmoid colon

304

2074

1.48

9.55

1.6

1.7

—

ILD and respiratory illness in diseases classified elsewhere

5.10

9.54

1.2

1.4

—

Golimumab

183

2.73

9.54

1.3

1.6

—

Abnormal involuntary movements

192

1183

1.64

9.53

1.6

1.7

—

Postzoster neuralgia

135

3.10

9.48

1.6

—

Left ventricular outflow tract obstruction (LVOTO), broad definition

126

692

1.85

9.45

1.5

1.7

—

Scoliosis

102

523

1.97

9.42

1.4

1.6

—

Internal derangement of knee

417

2982

1.39

9.42

1.7

1.9

—

Keratitis

446

3262

1.38

9.38

1.6

1.7

—

Phobic anxiety disorders

101

515

1.97

9.35

1.6

1.7

—

Aortic valve malfunction, age under 60 years

122

666

1.86

9.35

1.6

1.7

—

Neuralgia and neuritis, unspecified

377

2.16

9.34

1.8

1.7

—

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

157

2.85

9.32

1.3

1.6

—

Malignant melanoma, including Hilmo

226

1455

1.57

9.32

1.8

1.2

—

5.23

9.31

1.3

1.4

—

Benign neoplasm: Adrenal gland

129

719

1.83

9.29

1.7

—

Alcohol use disorder, ICD-based

538

4057

1.33

9.26

1.3

1.7

—

Explicit fungal Sepsis

4.87

9.23

1.3

1.4

—

Explicit fungal Sepsis, including avohilmo

4.87

9.23

1.3

1.4

—

Faecal incontinence

142

815

1.77

9.23

1.4

1.7

—

Autoimmune hepatitis

4.62

9.21

1.2

2.3

—

Duodenal ulcer

180

1102

1.66

9.21

1.6

—

Atopic dermatitis, strict definition with reimbursement

237

1481

1.54

9.19

1.6

—

544

3529

1.34

9.17

1.4

1.6

—

Sacroiliitis, not elsewhere classified

210

2.56

9.16

1.3

1.6

—

Superficial injury of hip and thigh

225

1453

1.56

9.15

1.5

—

Other encephalitis

194

2.65

9.10

1.2

1.6

—

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

154

907

1.71

9.05

1.4

1.7

—

Chronic myeloproliferative disease

123

3.17

9.05

2.1

1.6

—

Syphilis

189

2.67

9.03

1.1

1.7

—

Syphilis, including avohilmo

189

2.67

9.03

1.1

1.7

—

Other inflammation of eyelid

200

1262

1.60

9.02

2.0

1.6

—

Redundant prepuce, phimosis and paraphimosis

251

1639

1.52

8.98

1.3

1.7

—

Carcinoma in situ of skin of other and unspecified parts of face

171

1043

1.67

8.96

1.7

1.5

—

All anxiety disorders

611

3635

1.31

8.96

1.6

1.7

—

Polycystic ovarian syndrome, consortium definition

723

3231

1.29

8.95

1.8

—

Disorders of magnesium metabolism

3.91

8.94

1.1

1.8

—

Intestinal adhesions without obstruction

132

749

1.79

8.94

1.7

1.6

—

Visual impairment including blindness (binocular or monocular)

119

655

1.85

8.94

1.3

1.5

—

Rare circulating lymphoid malignancy

7.15

8.91

2.0

1.3

—

Encephalitis

202

2.59

8.90

1.2

1.7

—

Malignant neoplasm of bladder, including Hilmo

176

1066

1.65

8.90

1.3

1.2

—

Other general symptoms and signs

247

2.40

8.87

1.3

1.6

—

Other noninflammatory disorders of uterus, except cervix

286

1289

1.49

8.86

1.8

—

Malignant melanoma

201

1276

1.59

8.84

1.8

1.2

—

Infective dermatitis

156

931

1.70

8.81

1.3

1.7

—

Haemophagocytic lymphohistiocytosis

18.80

8.77

1.7

1.1

—

Abscess of lung

125

3.09

8.77

1.5

1.6

—

Colorectal cancer, including Hilmo

353

2340

1.42

8.75

1.6

1.2

—

Panic disorder

122

679

1.81

8.74

1.4

1.7

—

Other or ill-defined heart diseases

328

2.20

8.71

1.4

1.6

—

Invasive ventilation

116

639

1.85

8.70

1.4

1.7

—

Other nonautoimmune haemolytic anaemias

10.22

8.70

2.4

1.2

—

Paraplegia, diplegia of upper limbs

164

2.77

8.70

1.4

1.7

—

Migraine with aura

211

1357

1.56

8.68

1.7

1.8

—

Congenital malformations of trachea and bronchus

4.00

8.67

1.2

1.9

—

Use of pramipexole

324

2280

1.43

8.66

1.5

1.7

—

Papillary adenocarcinoma of thyroid gland

278

2.30

8.64

1.8

1.2

—

Other bacterial agents as the cause of diseases classified to other chapters, including avohilmo

3.41

8.63

2.3

1.8

—

Mental and behavioural disorders due to tobacco

119

662

1.82

8.62

1.5

1.8

—

Special screening examination for other diseases and disorders

141

822

1.73

8.61

1.3

1.6

—

Varicella [chickenpox], including avohilmo

253

2.37

8.61

2.9

1.5

—

Vitamin deficiency, wide

350

2.16

8.60

1.4

1.6

—

Vitamin deficiency

350

2.16

8.60

1.4

1.6

—

243

2.43

8.59

1.5

1.7

—

Erythema multiforme

165

2.75

8.59

1.7

—

Conjunctivitis

858

5555

1.25

8.59

1.9

1.7

—

Corticotropin deficiency

4.10

8.58

1.3

1.8

—

Crohn's disease NAS

410

2.06

8.57

1.5

1.6

—

Other blood glucose lowering drugs, excl. Insulins

244

1631

1.51

8.54

1.3

1.7

—

Other disorders of glucose regulation and pancreatic internal secretion

115

635

1.84

8.53

1.3

1.6

—

Psoriatic arthropathies

117

649

1.82

8.53

1.5

1.9

—

Transport accidents

503

3152

1.33

8.53

1.6

1.7

—

Cervicalgia

258

1743

1.49

8.51

1.6

—

Complications of cardiac and vascular prosthetic devices, implants and grafts

190

2.62

8.47

1.6

1.7

—

Other noninfective disorders of lymphatic vessels and lymph nodes

275

2.31

8.46

1.3

1.7

—

Prurigo nodularis

214

2.51

8.44

1.3

1.7

—

Covid-19 suspected case

204

1313

1.56

8.42

1.8

1.7

—

Pure hyperglyceridaemia

161

2.75

8.42

1.4

1.6

—

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

117

653

1.82

8.42

1.6

—

Systemic sclerosis, icd10

191

2.60

8.36

1.3

1.6

—

Lung transplant status

4.46

8.35

1.3

1.9

—

Lung transplantation

4.46

8.35

1.3

1.9

—

Diplopia

185

1170

1.60

8.32

1.5

1.6

—

Benign neoplasm: Rectum

286

1986

1.46

8.27

1.5

1.6

—

Flat foot [pes planus] (acquired)

118

663

1.80

8.27

1.3

1.9

—

Other mental disorders due to brain damage and dysfunction and to physical disease

203

1316

1.56

8.24

1.4

1.6

—

Smoking dependency

119

672

1.80

8.22

1.5

1.7

—

Benign neoplasm: Rectum, anus and anal canal

314

2220

1.43

8.22

1.5

1.6

—

Mixed and other personality disorders

376

2.07

8.19

1.5

1.6

—

Defects in the complement system

6.67

8.19

1.8

1.7

—

Nummular dermatitis

124

710

1.77

8.19

1.3

1.7

—

Adenocarcinoma and Papillary adenocarcinoma of kidney

3.91

8.18

1.2

—

Unspecified misadventure during surgical and medical care

503

1.93

8.12

1.5

1.7

—

Other nutritional anaemias

3.68

8.09

1.0

1.4

—

Intracranial and intraspinal abscess and granuloma

3.42

8.08

1.2

1.8

—

Malignant neoplasm of respiratory system and intrathoracic organs, including Hilmo

323

1884

1.42

8.06

1.6

1.2

—

Varicella [chickenpox]

230

2.39

8.05

3.1

1.5

—

Raynaud syndrome

111

618

1.82

8.04

1.3

1.6

—

Benign neoplasm: Transverse colon

180

1143

1.60

8.02

1.8

1.7

—

Psoriasis (vulgaris), strict definition

219

2.43

7.99

1.2

1.8

—

Allergic bronchopulmonary aspergillosis (ABPA)

10.24

7.98

1.1

2.1

—

Other hearing loss

463

3387

1.33

7.97

1.6

—

Chronic myeloid leukaemia, including Hilmo

4.81

7.97

1.0

1.3

—

Personal history of other diseases and conditions

453

1.95

7.95

2.9

1.4

—

Mucosal proctocolitis

137

813

1.70

7.92

1.4

1.7

—

Alcohol-induced acute pancreatitis

264

2.29

7.92

1.4

1.7

—

Menorrhagia

346

1372

1.41

7.91

1.6

1.7

—

Benign neoplasm of mouth and pharynx

154

945

1.65

7.88

2.1

1.6

—

Acquired absence of limb

3.69

7.83

2.2

1.2

—

Bacterial, viral and other infectious agents

100

544

1.86

7.81

2.1

1.6

—

Migraine

457

2673

1.33

7.80

1.7

1.9

—

Need for immunization against other single viral diseases

128

2.91

7.80

1.6

1.5

—

Cholecystectomy

956

6685

1.22

7.78

1.5

1.7

—

Crohn's disease of small intestine

426

1.97

7.74

1.4

1.6

—

Artificial opening status

476

1.93

7.74

1.5

1.4

—

Chronic rhinitis, nasopharyngitis and pharyngitis

378

2783

1.37

7.71

1.6

1.8

—

Cholangitis (primary sclerosing, PSC), with reimbursement 202

107

3.08

7.70

1.5

1.6

—

Other chondrocalcinosis

130

2.91

7.67

1.3

1.7

—

KRA_PSY_EATING, excluding more controls

172

2.55

7.66

1.8

1.5

—

Malignant neoplasm of colon, including Hilmo

248

1694

1.47

7.64

1.6

1.2

—

Inguinal hernia

779

4167

1.25

7.64

1.6

1.7

—

Alcohol-induced chronic pancreatitis

492

1.90

7.63

1.5

1.7

—

Other inflammation of eyelid, including avohilmo

474

3613

1.32

7.63

1.9

1.7

—

Retinal vascular occlusion

203

1341

1.53

7.60

1.5

1.6

—

Diabetic maculopathy

194

1197

1.55

7.58

1.4

1.5

—

Other benign neoplasms of skin

519

4013

1.30

7.57

1.8

1.6

—

Gonarthrosis, primary, with knee surgery

893

5699

1.23

7.56

1.5

1.7

—

Fracture of foot, except ankle

266

1853

1.44

7.54

1.9

1.7

—

Benign neoplasm: Stomach

151

934

1.64

7.53

1.6

—

Glaucoma

870

6054

1.23

7.51

1.5

1.7

—

Bacterial, viral and other infectious agents, including avohilmo

103

573

1.82

7.50

2.1

1.7

—

Benign neoplasm: Caecum

178

1147

1.57

7.48

1.6

1.7

—

Lesion of lateral popliteal nerve

370

2.04

7.48

2.3

1.6

—

Pemphigoid

278

2.23

7.48

1.1

1.6

—

Malignant neoplasm of mesothelium and soft tissue, including Hilmo

474

1.91

7.47

2.5

1.2

—

Left bundle-branch block

104

582

1.81

7.46

1.4

1.6

—

Amputation of thigh

311

2.15

7.45

1.3

1.5

—

Other and unspecified effects of external causes

273

1915

1.43

7.44

1.9

1.7

—

Disorders of ocular muscles, binocular movement, accommodation and refraction

517

3966

1.30

7.43

1.6

1.7

—

Infarction of spleen

4.09

7.43

1.1

1.5

—

Other disorders of eye and adnexa

163

1029

1.60

7.41

1.5

1.7

—

Trochanteric bursitis

195

1283

1.53

7.40

1.8

—

Injury of unspecified body region

113

650

1.76

7.39

1.4

1.6

—

Pre-eclampsia or eclampsia

182

1179

1.55

7.37

1.7

1.8

—

Ovarian cyst

335

1374

1.40

7.37

1.7

—

Voice disturbances

348

2551

1.37

7.37

1.6

1.7

—

Tobacco use

386

2.00

7.35

1.5

1.7

—

Other disorders of skin and subcutaneous tissue in diseases classified elsewhere

17.74

7.35

1.7

1.1

—

Pre-eclampsia

165

1047

1.59

7.32

1.8

—

Amyloidosis of skin

23.55

7.32

1.7

1.0

—

Vitamin D deficiency

116

2.93

7.29

1.2

1.8

—

Other sleep disorders

142

871

1.65

7.29

1.5

1.7

—

Multifocal fibrosclerosis

4.32

7.23

1.3

1.7

—

Open wound of forearm

128

767

1.69

7.21

1.5

1.6

—

Umbilical hernia

353

2603

1.37

7.21

1.4

1.8

—

Coxibs

363

1388

1.38

7.15

1.5

1.6

—

Other secondary coxarthrosis

283

2.17

7.13

1.1

1.7

—

Disorders of phosphorus metabolism and phosphatases

6.81

7.12

1.8

1.4

—

Emotionally unstable personality disorder

452

1.89

7.12

1.3

1.7

—

Systemic disorders of connective tissue in diseases classified elsewhere

8.23

7.11

4.7

1.2

—

Protein-energy malnutrition of moderate and mild degree

3.55

7.10

1.2

1.5

—

Fall on and from stairs and steps

338

2482

1.37

7.09

1.5

1.7

—

Fracture of skull and facial bones

261

1835

1.43

7.08

1.8

1.7

—

Systemic disorders of connective tissue in diseases classified elsewhere (FG)

12.60

7.07

5.6

1.1

—

Other/unspecified crystal arthropathies

3.81

7.05

1.3

1.8

—

Benign neoplasm: Descending colon

117

691

1.72

7.02

1.3

1.7

—

Retinal vascular disorders

203

1365

1.51

7.02

1.5

1.6

—

Cervicobrachial syndrome

244

1697

1.45

7.02

1.5

1.7

—

Personality disorders

225

1541

1.47

6.99

1.4

1.7

—

Systemic sclerosis,strict definition

3.72

6.99

1.3

1.7

—

Speech disturbances, not elsewhere classified

141

875

1.63

6.97

1.5

1.6

—

Pleural plaque

174

1136

1.56

6.96

1.5

1.6

—

COPD, hospital admissions 1, only main diagnosis

556

3763

1.28

6.95

1.4

1.6

—

Recurrent or chronic depression

394

2044

1.34

6.92

1.6

1.9

—

Pneumonitis due to solids and liquids

135

831

1.65

6.90

1.3

1.5

—

Presbycusis

254

1767

1.43

6.88

1.5

—

Acidosis

179

2.48

6.88

1.3

1.6

—

Focal epilepsy

268

1904

1.42

6.86

1.4

1.6

—

Aspergillosis

3.39

6.85

1.6

—

Aspergillosis, including avohilmo

3.38

6.85

1.6

—

Other/unspecified synovitis and tenosynovitis

142

886

1.62

6.83

1.3

1.8

—

Carcinoma in situ of skin of scalp and neck

323

2.08

6.82

1.4

1.5

—

Specific personality disorders

194

1298

1.50

6.79

1.3

1.7

—

Nonorganic sleeping disorders, excluding more controls

193

1291

1.50

6.77

1.4

1.7

—

Disease of hard tissues of teeth, NOS

695

2921

1.25

6.77

1.7

1.5

—

Sequelae of injuries, of poisoning and of other consequences of external causes

276

1977

1.41

6.76

2.0

1.7

—

Malignant neoplasm of mesothelium and soft tissue

269

2.16

6.75

3.1

1.2

—

Non-neuropathic heredofamilial amyloidosis

17.64

6.74

2.2

1.3

—

Congenital malformations of the respiratory system

105

2.94

6.70

1.5

1.8

—

Malignant neoplasm of small intestine

139

2.66

6.70

1.8

1.3

—

Total colectomy operation

277

2.13

6.67

1.4

1.7

—

Total colectomy

277

2.13

6.67

1.4

1.7

—

Hypergammalglobulinemia, unspecified

23.00

6.63

1.7

1.0

—

Other diseases of spinal cord

226

2.26

6.62

1.9

1.7

—

Disorders of orbit

339

2.01

6.61

1.6

1.7

—

Iron deficiency

100

2.94

6.60

1.3

1.8

—

Impacted cerumen

175

1157

1.53

6.59

1.7

1.6

—

Malignant neoplasm of breast, including Hilmo

391

1883

1.34

6.58

1.7

1.2

—

Other and unspecified psoriasis

562

1.77

6.54

1.3

1.7

—

Carcinoma in situ of skin of trunk

363

1.98

6.51

1.9

1.6

—

Other bursopathies

180

1200

1.51

6.50

1.7

—

Radiculopathy

212

1460

1.46

6.49

1.7

1.6

—

Agoraphobia

101

2.91

6.49

1.9

1.5

—

Henoch-Schönlein purpura nephritis (HSPN)

8.82

6.49

1.3

1.4

—

Malignant neoplasm of breast, HER2-negative, including Hilmo

390

1883

1.33

6.46

1.7

1.2

—

6-mercaptopurine

118

2.75

6.46

1.2

1.8

—

Striking against or struck by other objects

353

2645

1.34

6.44

1.4

1.7

—

Abnormal findings on diagnostic imaging of central nervous system

356

1.97

6.43

1.4

1.7

—

Malignant melanoma of skin, including Hilmo

176

1170

1.52

6.43

1.6

1.2

—

Progressive systemic sclerosis

5.47

6.40

1.3

2.0

—

Inflammatory diseases of prostate (prostatitis)

184

1237

1.50

6.40

1.4

1.7

—

Other or unspecified immunodeficiency

7.62

6.39

1.3

1.4

—

Familial hypercholesterolemia, with ischemic heart disease

159

1039

1.55

6.37

1.2

1.7

—

Atopic dermatitis, strict definition

215

1454

1.45

6.36

1.6

—

Other disorders of eyelid

667

5119

1.24

6.36

1.5

1.6

—

Fall on same level involving ice and snow

734

6033

1.22

6.31

1.6

1.7

—

Nonsuppurative otitis media, including avohilmo

276

1724

1.39

6.29

1.7

1.6

—

Excessive, frequent and irregular menstruation

352

1394

1.35

6.29

1.6

1.7

—

Seborrhoeic dermatitis

133

836

1.61

6.27

1.6

1.7

—

Inflammatory diseases of female pelvic organs

614

3374

1.25

6.26

1.6

1.8

—

Procreative management

288

1728

1.38

6.20

1.6

1.7

—

Colonic or urogenital fistula

331

2478

1.34

6.19

1.7

—

Amiodarone users

164

1087

1.53

6.16

1.5

1.7

—

Fitting and adjustment of other devices

523

3658

1.27

6.15

1.7

1.5

—

Congenital malformations of the respiratory system, including avohilmo

116

2.74

6.15

1.5

1.8

—

Infection due to other mycobacteria, including avohilmo

122

2.70

6.14

1.3

1.6

—

Wegener granulomatosis

105

2.86

6.14

1.7

—

Portal vein thrombosis

128

2.67

6.14

1.7

1.9

—

Malignant neoplasm of eye and adnexa, including Hilmo

3.10

6.14

2.0

1.3

—

Strabismus

283

2065

1.37

6.13

1.6

1.7

—

Other female pelvic inflammatory diseases

175

1175

1.50

6.12

1.5

1.8

—

Malignant neoplasm of bronchus and lung, including Hilmo

283

1722

1.38

6.11

1.4

1.2

—

Malignant neoplasm of breast

383

1874

1.32

6.10

1.7

1.3

—

Alzheimer disease, excluding more controls

272

1269

1.40

6.08

1.6

1.7

—

Focal epilepsy, strict definition

248

1780

1.40

6.06

1.4

1.6

—

Monoarthritis, not elsewhere classified

281

2.06

6.06

1.2

2.0

—

Superficial injury of abdomen, lower back and pelvis

178

1203

1.49

6.02

1.6

—

Overexertion and strenuous or repetitive movements

117

720

1.64

6.02

1.9

1.7

—

Malignant neoplasm of breast, HER2-negative

382

1873

1.32

6.01

1.7

1.3

—

Rosacea

148

963

1.55

6.01

1.5

1.7

—

therapeutic use

283

2.06

6.00

2.4

1.6

—

Necrosis of pulp, including avohilmo

632

5085

1.23

5.99

1.9

1.7

—

Other specified and unspecified personality disorders

480

1.79

5.97

1.3

1.7

—

Speech and linguistic disorders, excluding more controls

276

2.02

5.96

1.4

1.6

—

Malignant neoplasm of liver and intrahepatic bile ducts, including Hilmo

359

1.92

5.96

1.2

—

Later onset COPD

503

3205

1.27

5.96

1.4

1.6

—

Cytomegaloviral pneumonitis

8.89

5.94

2.3

1.2

—

Disorders of vestibular function (Vertigo)

651

5186

1.23

5.94

1.7

—

Paralytic ileus

325

1.98

5.93

1.4

1.5

—

378

2709

1.31

5.92

1.5

1.6

—

Benign paroxysmal vertigo

409

3176

1.30

5.91

1.8

1.7

—

Other shoulder lesions

109

662

1.66

5.91

1.3

1.8

—

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

179

1217

1.48

5.88

2.0

1.7

—

Other mycoses, not elsewhere classified/unspecified

6.06

5.86

2.6

1.5

—

Chronic laryngitis and laryngotracheitis

182

1244

1.48

5.85

1.6

1.7

—

Rapidly progressive nephritic syndrome

7.49

5.83

2.0

1.5

—

Malignant neoplasm of small intestine, including Hilmo

193

2.27

5.82

1.7

1.2

—

Infection due to other mycobacteria

114

2.71

5.81

1.3

1.6

—

Chronic conjunctivitis

213

2.20

5.78

1.4

1.8

—

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

627

4939

1.23

5.76

1.6

1.7

—

Other erythematous conditions

308

1.99

5.75

1.9

1.7

—

Combinations of oral blood glucose lowering drugs

394

3057

1.30

5.75

1.3

1.8

—

Eating disorder

199

2.22

5.75

1.8

1.5

—

Common variable immunodeficiency

5.01

5.74

1.1

2.0

—

Congenital malformations and deformations of the musculoskeletal system

375

1.87

5.73

1.5

1.6

—

Other factor of the environment

3.13

5.72

1.5

1.7

—

Liver disorders in diseases classified elsewhere

9.25

5.71

1.2

1.1

—

Other Crohn's disease

400

1.84

5.69

1.5

1.6

—

Abnormal findings in nipple discharge synovial fluid wound secretions

104

2.78

5.68

1.4

1.6

—

Renal cell carcinoma of kidney

228

2.15

5.66

1.2

—

Pre-eclampsia or poor fetal growth

208

1458

1.43

5.66

1.7

1.8

—

Bullous pemphigoid

216

2.20

5.64

1.1

1.7

—

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

158

1058

1.50

5.62

2.0

1.7

—

Persistent mood disorders

215

1527

1.42

5.62

1.4

1.7

—

Wet age-related macular degeneration

301

2177

1.34

5.62

1.4

1.5

—

Superficial injury of head

306

2298

1.34

5.61

1.3

1.6

—

Hepatocellular carcinoma, including Hilmo

190

2.25

5.59

1.2

—

Ulcer of oesophagus

104

635

1.66

5.59

1.7

—

Personal history of medical treatment

3.17

5.57

1.0

1.3

—

Coxarthrosis, primary, with hip surgery

723

5578

1.21

5.56

1.6

1.7

—

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

312

1.96

5.55

1.7

1.6

—

Acquired pure red cell aplasia [erythroblastopenia]

5.59

5.55

1.5

1.4

—

Drug-induced Cushing's syndrome

13.46

5.55

1.3

1.5

—

Other specified/unspecified bacterial intestinal infections

560

1.70

5.54

2.0

1.6

—

Infections with a predominantly sexual mode of transmission, including avohilmo

284

1930

1.35

5.53

1.6

1.7

—

Endometriosis

315

1369

1.34

5.51

1.7

1.8

—

Adult respiratory distress syndrome

106

2.74

5.50

2.2

1.8

—

Other and unspecified erythematous conditions

272

2.03

5.48

2.0

1.7

—

Other disorders of pigmentation

370

1.87

5.48

1.8

1.6

—

Malignant neoplasm of testis, including Hilmo

3.39

5.47

1.5

1.2

—

Osteomyelitis of vertebra

5.54

5.46

2.1

1.2

—

Erosion of teeth , including avohilmo

247

1804

1.38

5.46

1.8

1.7

—

Microscopic polyangiitis

3.76

5.44

1.2

1.4

—

Colorectal cancer

299

2158

1.34

5.44

1.7

1.2

—

Social phobias

285

1.98

5.43

1.6

—

Post-traumatic stress disorder

251

2.04

5.43

1.4

1.6

—

Malignant melanoma of skin

143

946

1.53

5.43

1.6

1.2

—

Other and unspecified vascular occlusions

152

1020

1.51

5.43

1.5

—

Ulcerative enterocolitis

186

2.24

5.42

1.4

1.7

—

Disorders of tooth development and eruption

152

823

1.51

5.41

1.7

1.6

—

Other and unspecified diseases of spleen

5.40

5.41

1.6

1.8

—

Malignant neoplasm of head and neck, including Hilmo

118

749

1.59

5.39

1.9

1.2

—

Panhypopituitarism

125

2.55

5.36

1.3

1.6

—

Dilated cardiomyopathy

176

1220

1.46

5.34

1.4

1.7

—

Exposure to other specified factors

937

6858

1.18

5.34

1.7

—

Focal epilepsy, mode (most common among epilepsy diagnosis)

230

1669

1.39

5.33

1.4

1.6

—

Diseases of inner ear

743

5955

1.20

5.31

1.7

—

Hyperosmolality and hypernatraemia

114

2.63

5.30

1.4

—

Event of undetermined intent

388

1.82

5.30

1.7

1.6

—

Sulfonylureas

535

3444

1.24

5.29

1.3

1.6

—

Hypoglycaemia, other or unspecified

499

1.72

5.29

1.2

1.6

—

Coronary artery bypass grafting

400

2321

1.29

5.29

1.3

1.6

—

Other diseases of biliary tract

125

809

1.56

5.28

1.3

1.6

—

Benign thyroid growths and nodules

418

3067

1.27

5.28

1.5

1.8

—

Hypertension, portal

5.71

5.27

1.1

—

Other injuries of lower limb, level unspecified

3.24

5.27

1.2

1.5

—

Psychotic depression

360

1.85

5.25

1.4

1.7

—

Ulcerative colitis (strict definition, require KELA)

163

1115

1.47

5.25

2.0

1.7

—

Febrile neutrophilic dermatosis [Sweet]

11.69

5.25

5.2

1.2

—

Other specified disorders of kidney and ureter

256

2.03

5.24

1.2

1.7

—

Disorders of vitreous body and globe

729

5774

1.20

5.23

1.8

1.7

—

Other other unspecified disorders of the circulatory system

298

1.95

5.22

1.5

1.6

—

Acute lymphadenitis

340

1.87

5.20

1.5

1.7

—

Retinal detachments and breaks

510

4135

1.24

5.18

1.8

1.7

—

Unspecified contracted kidney

4.71

5.17

1.1

1.4

—

Polymyositis

3.22

5.17

2.8

1.8

—

Membranous nephropathy

5.09

5.15

1.3

—

Congenital malformations and deformations of the musculoskeletal system, including avohilmo

529

1.68

5.15

1.5

1.6

—

Seborrhoeic keratosis

351

2726

1.30

5.15

1.8

1.6

—

Migraine with aura and triptan purchases

109

686

1.60

5.15

1.8

1.7

—

Kyphosis

104

2.68

5.14

1.6

1.7

—

Other disorders of peripheral nervous system

3.73

5.14

1.6

1.4

—

Encephalopathy

3.01

5.12

1.8

1.5

—

Viral haemorrhagic fevers, not elsewhere classified/unspecified, including avohilmo

186

1311

1.43

5.12

1.7

1.6

—

Malignant neoplasm of colon

193

1372

1.42

5.08

1.7

1.2

—

Impetigo

231

2.06

5.08

1.8

1.6

—

Other or unspecified common variable immunodeficiency

7.43

5.07

1.2

—

Other extrapyramidal and movement disorders in other diseases

332

2565

1.30

5.07

1.4

1.7

—

Viral hepatitis

401

1.79

5.06

1.3

1.7

—

Benign neoplasm: Skin of other and unspecified parts of face

147

995

1.49

5.05

1.7

1.6

—

Oter anti-inflammatory and antirheumatic agents, non-steroids

320

1335

1.32

5.05

1.4

1.6

—

Malignant neoplasm of anus and anal canal, including Hilmo

3.05

5.05

1.1

1.3

—

Other epidermal thickening

388

1.81

5.03

1.2

1.7

—

Complications of other internal prosthetic devices, implants and grafts

374

1.82

5.02

2.0

1.6

—

Sweet's syndrome

10.51

5.00

5.2

1.2

—

Disorders of psychological development

378

1.77

5.00

1.3

1.5

—

Causalgia

2.79

4.99

1.2

1.8

—

Thiazolidinediones

164

1138

1.46

4.98

1.3

1.7

—

Acquired coagulation factor deficiency

10.28

4.97

3.1

1.2

—

Acetic acid derivatives and related substances

348

1383

1.31

4.95

1.4

1.6

—

Myositis

214

2.10

4.95

2.0

1.7

—

Other viral hepatitis

310

1.89

4.94

1.3

1.7

—

Migraine without aura and triptan purchases

106

670

1.59

4.93

1.6

1.7

—

Bell's palsy

142

959

1.49

4.93

1.6

—

Trigger finger

168

1172

1.44

4.92

1.5

1.8

—

Seronegative juvenile rheumatoid arthritis

3.27

4.92

1.1

1.6

—

Barrett oesophagus

458

1.73

4.92

1.6

1.8

—

Right bundle-branch block

290

1.93

4.92

1.3

1.6

—

malignant neoplasm of female genital organs, including Hilmo

188

1274

1.42

4.91

1.7

1.2

—

Crohn disease (strict definition, require KELA, min 2 HDR)

354

1.83

4.90

1.5

1.6

—

Mixed hyperlipidaemia

319

1.88

4.89

1.2

1.6

—

Moderate visual impairment, binocular

277

1.95

4.88

1.2

1.4

—

Unknown and unspecified causes of morbidity

413

1.76

4.88

1.4

1.5

—

Malignant neoplasm of eye, brain and central nervous system, including Hilmo

428

1.75

4.88

1.8

1.2

—

Status post-ami

394

2363

1.27

4.85

1.3

1.6

—

Disorders of purine and pyrimidine metabolism

3.60

4.85

1.3

1.2

—

Hyperfunction of pituitary gland

256

1.98

4.85

1.8

1.6

—

Malignant neoplasm of corpus uteri, including Hilmo

113

730

1.56

4.84

1.5

1.3

—

Other disorders of bone density and structure

150

2.31

4.84

2.2

1.6

—

Injuries to the neck

236

1751

1.35

4.79

1.8

1.6

—

Alopecia areata

157

2.27

4.79

1.4

1.6

—

Malignant neoplasm of respiratory system and intrathoracic organs

272

1704

1.33

4.79

1.6

1.2

—

Other and unspecified mood [affective] disorders

306

1.88

4.79

1.7

1.6

—

Suggestive for eosinophilic asthma

119

780

1.54

4.79

1.4

1.7

—

Metatarsalgia

109

700

1.57

4.79

1.2

1.7

—

Erythema nodosum

210

2.09

4.78

1.9

1.7

—

Demyelinating diseases of the central nervous system

461

1.71

4.76

1.3

1.6

—

Malignant neoplasm of corpus uteri

105

670

1.58

4.76

1.5

1.2

—

Ethmoidectomy

141

958

1.48

4.76

1.7

—

Polyarteritis with lung involvement [Churg-Strauss]/EGPA

5.36

4.75

1.3

1.9

—

Hyperhidrosis

145

2.30

4.72

1.2

1.7

—

Injury of blood vessels at shoulder and upper arm level

9.19

4.72

1.6

1.1

—

Disorders of parathyroid gland, other and/or unspecified

3.06

4.72

1.2

1.6

—

FESS (DNB20)

135

911

1.49

4.72

1.7

—

Speech and linguistic disorders

308

1.85

4.70

1.4

1.6

—

Impotence

479

1.69

4.70

1.4

1.8

—

Acute suppurative otitis media

169

1107

1.43

4.69

2.0

1.6

—

Paralytic strabismus

100

634

1.60

4.68

1.8

1.7

—

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

518

1.66

4.66

1.3

1.2

—

Lagophthalmos

122

2.47

4.66

1.2

1.8

—

Algoneurodystrophy

166

2.20

4.62

1.2

1.7

—

Other and unspecified injuries of lower leg

496

1.67

4.61

1.4

1.8

—

Disorders of vitreous body

703

5655

1.19

4.60

1.8

1.7

—

Selective deficiency of immunoglobulin G [IgG] subclasses

4.36

4.60

1.3

1.9

—

Crohn's disease of large intestine

311

1.86

4.59

1.3

1.6

—

Recurrent and persistent haematuria

3.17

4.59

1.2

1.8

—

Crohn disease (strict definition, require KELA)

362

1.79

4.58

1.5

1.6

—

Melanocytic naevi

330

2584

1.28

4.57

1.7

—

Viral hepatitis, including avohilmo

422

1.72

4.55

1.3

1.7

—

Other disorders of patella

140

958

1.47

4.55

1.7

1.9

—

Crohn disease (strict definition, all UC cases excluded)

305

1.86

4.54

1.4

1.6

—

Malignant neoplasm of tonsil, including Hilmo

2.70

4.53

1.9

1.3

—

Fluid overload

5.07

4.52

1.2

1.3

—

Superficial injury of thorax

183

1318

1.40

4.52

1.6

—

Listeriosis, including avohilmo

4.31

4.52

5.0

1.3

—

Testicular dysfunction

242

1.97

4.52

2.4

1.7

—

Lifestyle-related condition

2.85

4.51

1.2

1.5

—

Alcohol induced polyneuropathy

2.79

4.50

1.5

—

Exfoliative dermatitis

2.78

4.49

1.8

1.3

—

Status epilepticus

264

1.92

4.48

1.2

1.7

—

Carcinoma in situ of skin of upper limb, including shoulder

301

1.88

4.48

1.6

—

Hypertension, Pulmonary Arterial

3.11

4.47

1.1

2.2

—

Other demyelinating diseases of the central nervous system

175

2.14

4.46

1.6

1.7

—

Congenital malformations of the circulatory system

135

895

1.47

4.45

1.4

1.7

—

Orthopaedic devices associated with adverse incidents

190

2.12

4.44

1.8

1.7

—

Other enthesopathy of foot (+metatarsalgia)

112

737

1.53

4.44

1.2

1.7

—

Other viral hepatitis, including avohilmo

329

1.81

4.43

1.3

1.7

—

Respiratory conditions due to other external agents

183

2.13

4.43

1.8

1.6

—

Exophthalmic conditions

2.82

4.42

1.3

1.9

—

Arthropathy in hypersensitivity reactions classified elsewhere

13.26

4.42

1.4

1.0

—

Nail disorders

627

1.58

4.42

1.5

1.7

—

Pleural plaque with presence of asbestos

128

870

1.49

4.41

1.6

1.7

—

Alcohol dependence

326

2563

1.28

4.40

1.3

1.7

—

Disorders of sphingolipid metabolism and other lipid storage disorders

5.89

4.39

1.6

1.3

—

Carcinoma in situ of colon

281

1.89

4.39

1.2

1.7

—

Contact with other and unspecified heat and hot substances

4.42

4.39

1.9

1.7

—

Cervicocranial syndrome

120

804

1.50

4.38

1.5

1.6

—

Alcohol abuse, main dg, excluding more controls

153

1075

1.43

4.36

1.2

1.8

—

Malignant neoplasm of testis

3.25

4.36

1.6

1.2

—

Unspecified/other endometriosis

345

1.77

4.35

1.5

1.7

—

Glaucoma secondary to other eye disorders

354

1.78

4.35

1.3

1.7

—

Other and unspecified tonsillitis

231

1436

1.34

4.35

1.8

1.6

—

Other and unspecified rosacea

108

709

1.54

4.35

1.6

1.7

—

Aortic aneurysm

350

2726

1.27

4.34

1.7

1.6

—

Diseases of tongue

459

1.67

4.33

1.5

1.4

—

Carcinoma in situ of skin

137

947

1.46

4.32

1.8

1.6

—

Injuries to the ankle and foot

755

5506

1.17

4.32

1.6

1.7

—

Primary adrenocortical insufficiency

2.78

4.32

1.1

1.9

—

Nonalcoholic steatohepatitis

2.94

4.29

1.8

—

Xerosis cutis

159

2.20

4.29

1.1

1.7

—

Secondary parkinsonism, excluding more controls

192

2.07

4.28

1.2

1.8

—

Neovascular glaucoma

356

1.77

4.28

1.3

1.6

—

Other and unspecified disorders of orbit

3.61

4.27

1.2

1.6

—

Juvenile rheumatoid arthirtis

2.73

4.27

1.0

1.9

—

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

534

4248

1.21

4.27

1.6

1.7

—

Excessive earwax

859

6727

1.16

4.27

1.7

—

Corneal ulcer

194

1425

1.37

4.27

1.5

1.6

—

Other enthesopathies

322

2537

1.27

4.26

1.7

1.9

—

Enthesopathies of lower limb, excluding foot

233

1760

1.33

4.25

1.6

1.7

—

Other and unspecified localized connective tissue disorders

6.32

4.23

1.1

1.5

—

Adult-onset Still disease

5.54

4.22

1.6

1.2

—

Background retinopathy and retinal vascular changes

180

2.10

4.21

1.5

1.7

—

Lupus nephritis

6.22

4.21

1.1

3.7

—

Heartburn

125

852

1.48

4.20

1.8

1.7

—

Olecranon bursitis

541

1.61

4.20

1.5

1.7

—

Polyclonal hypergammaglobulinaemia

11.87

4.20

5.0

1.1

—

Brain meningioma, including Hilmo

336

1.78

4.18

2.0

1.2

—

Benign neoplasm: Rectosigmoid junction

412

1.71

4.17

1.3

1.7

—

CR(E)ST syndrome

122

2.36

4.17

1.4

1.6

—

Post-traumatic wound infection, not elsewhere classified

194

2.05

4.17

1.7

1.6

—

Generalized anxiety disorder

110

730

1.51

4.16

1.4

1.7

—

Paget disease

3.39

4.16

1.3

1.2

—

Nonorganic sleeping disorders

193

1423

1.36

4.15

1.4

1.7

—

Urethral stricture

559

1.60

4.14

1.7

—

Other follicular disorders

465

1.65

4.13

1.3

1.7

—

Mouth breathing

456

3745

1.22

4.11

1.7

—

Alcoholic gastritis

104

2.47

4.11

1.2

1.8

—

Spontaneous rupture of synovium and tendon

107

711

1.52

4.10

1.3

1.7

—

Scleritis and episcleritis

413

1.69

4.09

1.3

1.6

—

Carcinoma in situ of other and unspecified digestive organs

445

1.67

4.08

1.2

1.6

—

Deficiency of other B group vitamins

162

2.14

4.08

1.5

1.7

—

Allergic conjunctivitis

557

4492

1.20

4.06

1.6

1.8

—

Recurrent dislocation and subluxation of joint

309

1.79

4.06

1.3

1.9

—

severe traumatic brain injury, does not include concussion

323

2566

1.27

4.05

1.5

—

Degenerative macular diseases

177

1296

1.38

4.03

1.5

1.6

—

Benign neoplasm: Pancreas

275

1.86

4.03

1.4

1.7

—

Malignant neoplasm of tonsil and base of tongue, including Hilmo

130

2.27

4.03

1.8

1.2

—

!Aliquae complicationes praecoces traumatis

318

1.78

4.02

1.7

1.6

—

Early complications of trauma

318

1.78

4.02

1.7

1.6

—

Pilonidal cyst

407

1.68

4.02

1.9

1.7

—

Pollen allergy

116

775

1.48

4.00

1.8

1.7

—

Tooth eruption problems

422

1.65

4.00

1.8

1.5

—

Listeriosis

4.01

3.99

5.3

1.3

—

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

378

1.70

3.98

1.3

1.9

—

Special screening examination for neoplasms

478

1.63

3.98

1.7

1.6

—

Atypical facial pain

379

1.71

3.97

1.4

1.6

—

Thyroiditis

486

1.62

3.97

1.6

—

Other bullous disorders

226

1.94

3.97

2.1

1.6

—

Other specified/unspecified spondylopathies

212

1.97

3.97

1.3

1.6

—

Colectomy operation

234

1791

1.32

3.96

1.6

—

Calcific tendinitis of shoulder

402

1.68

3.96

1.8

—

Other disorders of binocular vision

3.19

3.96

2.5

1.6

—

malignant neoplasm of female genital organs

165

1171

1.39

3.94

1.7

1.3

—

Malignant neoplasm of head and neck

605

1.55

3.93

1.4

1.2

—

Other superficial mycoses

125

2.28

3.93

1.4

1.6

—

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

395

1.69

3.93

1.4

1.7

—

Viral haemorrhagic fevers, not elsewhere classified/unspecified

630

1.54

3.92

1.9

1.7

—

Arterial embolism and thrombosis

559

1.57

3.91

1.7

1.5

—

Visual field defects

114

778

1.48

3.87

1.5

1.6

—

Other and unspecified visual disturbances

129

901

1.44

3.87

1.6

1.7

—

Nontoxic multinodular goitre

248

1919

1.30

3.87

1.5

1.7

—

Open wound of hip and thigh

193

2.00

3.85

1.1

1.6

—

Other meningitis

2.52

3.83

2.0

1.6

—

Alzheimer’s disease (Atypical or mixed), excluding more controls

145

769

1.42

3.82

1.2

1.5

—

Actinomycosis, including avohilmo

4.83

3.82

1.4

1.3

—

Malignant neoplasm of oral cavity, including Hilmo

279

1.81

3.81

1.8

1.2

—

Disorders of speech understanding and production

210

1.93

3.81

1.2

1.6

—

Malignant neoplasm of bronchus and lung

236

1515

1.31

3.81

1.4

1.2

—

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

115

789

1.47

3.80

1.9

1.7

—

Arthropod-borne viral fevers and viral haemorrhagic fevers, including avohilmo

202

1522

1.33

3.80

1.7

1.6

—

Other diseases of gallbladder

354

1.72

3.80

1.5

1.6

—

Malignant neoplasm of renal pelvis, including Hilmo

2.80

3.80

1.3

—

Somnolence, stupor and coma

339

1.73

3.79

1.2

1.6

—

Motor neuron disease ALS

147

2.15

3.79

1.3

1.8

—

Allergic contact dermatitis

120

830

1.45

3.78

1.6

1.7

—

Lichen simplex chronicus

266

1.83

3.77

1.8

1.7

—

Other strabismus

198

1484

1.33

3.76

1.4

1.7

—

Schizophrenia or delusion, excluding more controls

274

2126

1.28

3.75

1.4

1.8

—

Drug- and heavy-metal-induced tubulo-interstitial and tubular conditions

6.02

3.74

1.3

—

Specific development disorders of speech and language

249

1.83

3.73

1.3

1.6

—

Felty syndrome

3.27

3.73

1.4

2.0

—

Severe visual impairment, binocular

3.26

3.72

1.2

1.5

—

Examination and encounter for administrative purposes

100

670

1.51

3.72

1.5

1.6

—

Brain meningioma

326

1.74

3.72

1.8

1.2

—

Vascular dementia

159

1119

1.38

3.71

1.3

1.4

—

Cardiomyopathy, Hypertrophic obstructive

122

2.26

3.71

2.0

1.7

—

Testicular hypofunction

210

1.93

3.70

2.7

1.6

—

Burn and corrosion of ankle and foot

2.43

3.70

1.7

—

Embedded teeth, including avohilmo

326

1.73

3.69

1.8

1.5

—

Use of anticholinesterases

432

4011

0.83

3.68

1.3

1.6

—

N06DA Anticholinesterases

432

4011

0.83

3.68

1.3

1.6

—

Perforation of tympanic membrane

116

803

1.46

3.67

1.6

—

Motor neuron disease (with DMD)

149

2.12

3.67

1.3

1.8

—

Infective bursitis

240

1.87

3.65

2.3

1.8

—

Disseminated intravascular coagulation [defibrination syndrome]

5.10

3.64

2.5

1.2

—

Sphingolipidosis, other/unspecified

8.46

3.64

1.9

1.4

—

Benign neoplasm: Skin of eyelid, including canthus

201

1526

1.33

3.64

1.8

1.6

—

Oesophagitis

451

1.62

3.63

1.2

1.7

—

Propionic acid derivatives

345

1391

1.25

3.63

1.6

—

Otitis externa

247

1927

1.29

3.63

1.6

1.7

—

Haemolytic-uraemic syndrome

8.31

3.63

2.4

1.4

—

Arthropathic psoriasis

123

863

1.44

3.62

1.5

1.8

—

Non-small cell lung cancer, including Hilmo

187

1317

1.34

3.62

1.4

1.2

—

Entropion and trichiasis of eyelid

138

990

1.41

3.61

1.8

1.5

—

Presence of other devices

341

2720

1.24

3.61

1.6

1.5

—

Contact with and exposure to communicable diseases

188

1406

1.33

3.61

2.3

1.6

—

Malignant neoplasm of breast, HER-positive

297

1757

1.26

3.60

1.9

1.3

—

Adhesive capsulitis of shoulder

197

1493

1.33

3.60

1.4

1.8

—

Other acute viral hepatitis

2.71

3.60

1.3

1.6

—

Unspecified protein-energy malnutrition

3.18

3.59

1.1

1.3

—

Systemic atrophies primarily affecting the central nervous system

391

1.66

3.59

1.8

1.7

—

Other disorders of binocular movement

111

2.29

3.57

1.5

1.6

—

Malignant neoplasm of breast, ER-positive, including Hilmo

297

1757

1.26

3.57

1.9

1.3

—

Bulimia nervosa (incl. atypical)

2.67

3.57

1.3

1.5

—

Other specified/unspecified disorders of bone/cartilage

178

2.00

3.56

1.7

—

Malignant neoplasm of bone and articular cartilage of limbs

5.53

3.56

2.3

1.4

—

Hidradenitis suppurativa

171

2.01

3.55

1.4

1.7

—

Diffuse brain injury

206

1.91

3.55

1.4

1.7

—

Periapical abscess

522

4415

1.19

3.55

1.8

1.7

—

Cachexia

4.04

3.55

1.8

2.3

—

Chronic hepatitis NAS

2.43

3.53

1.1

1.7

—

Blindness, monocular

2.55

3.52

1.3

1.8

—

Temporomandibular joint disorders, including avohilmo

380

3022

1.22

3.52

1.8

—

Other psoriatic arthropathies

112

777

1.45

3.52

1.5

1.7

—

Psoriatic arthropathies, ICD10

115

802

1.45

3.51

1.5

1.7

—

Other forms of systemic lupus erythematosus

2.98

3.51

1.0

1.9

—

Dislocation, sprain and strain of joints and ligaments of thorax

243

1.84

3.51

2.0

1.7

—

Assault

670

1.48

3.51

1.4

1.6

—

Fracture at wrist and hand level

364

2971

1.23

3.50

1.7

—

Actinomycosis

4.80

3.50

1.3

1.4

—

Certolizumab pegol

2.51

3.49

1.3

1.7

—

Fracture of neck

592

1.52

3.48

1.8

1.6

—

Contact with other hot metals

100

2.35

3.47

1.3

1.5

—

Other drug-induced secondary parkinsonism

2.47

3.46

1.3

1.6

—

Chromosomal abnormalities, not elsewhere classified

2.91

3.46

1.9

1.6

—

Thoracic aortic aneurysm

204

1565

1.31

3.46

1.8

1.7

—

Ptosis of eyelid

158

1168

1.36

3.45

1.3

1.6

—

Diseases of middle ear and mastoid

544

3770

1.18

3.45

1.8

1.6

—

Malignant neoplasm of other and ill-defined sites, including Hilmo

2.39

3.44

1.5

1.2

—

Von Willebrand disease

2.71

3.43

1.5

1.8

—

Ménière disease

123

874

1.42

3.42

1.7

1.6

—

Immunodeficiency associated with other major defects

6.12

3.41

1.4

—

Extrapyramidal and movement disorders

535

4554

1.18

3.41

1.4

1.6

—

Other disorders of conjunctiva

189

1438

1.32

3.40

1.7

1.6

—

D07AA Corticosteroids, weak (group I)

129

922

1.40

3.40

1.6

—

Female genital prolapse

302

1340

1.26

3.40

1.5

1.8

—

Other secondary gout

4.65

3.39

2.8

1.2

—

Cerebral cysts

366

1.65

3.38

1.5

1.6

—

Malignant neoplasm of renal pelvis

3.56

3.37

1.1

1.2

—

Acute drug-induced interstitial lung disorder

2.64

3.37

2.4

1.8

—

Anti-inflammatory and antirheumatic products, non-steroids

342

1391

1.24

3.36

1.6

—

Other and unspecified bullous disorders

2.48

3.36

1.5

1.9

—

Attention to artificial openings

352

1.67

3.35

1.6

1.5

—

Dronedarone medication

240

1.82

3.35

1.3

1.6

—

Benign neoplasm: Small intestine

407

1.62

3.34

1.4

1.6

—

Complications of genitourinary prosthetic devices, implants and grafts

197

1.91

3.33

1.7

1.6

—

Drug-induced hypoglycaemia without coma

115

2.22

3.33

1.4

1.5

—

Other congenital malformations

437

1.59

3.32

1.4

1.6

—

Malignant neoplasm of tonsil and base of tongue

102

2.29

3.32

1.8

1.3

—

Other and unspecified mononeuropathies, also in other diseases

234

1.82

3.29

1.3

1.6

—

Other eating disorders

102

2.27

3.28

1.2

1.7

—

Malignant neoplasm of oropharynx, including Hilmo

109

2.24

3.28

1.9

1.2

—

Dental pulpitis, including avohilmo

766

5600

0.87

3.27

1.7

1.8

—

Secondary polycythaemia

177

1.96

3.27

1.2

1.7

—

Ulcerative rectosigmoiditis

551

1.52

3.27

2.0

1.6

—

Exposure to other and unspecified inanimate mechanical forces

519

1.53

3.27

2.0

1.7

—

Thyrotoxicosis

275

2205

1.25

3.26

1.8

1.7

—

Scabies

271

1.75

3.26

1.7

—

UC patients in KELA-register (code 208), prior to 1994

355

1.66

3.26

2.1

1.7

—

Other predominantly sexually transmitted diseases, not elsewhere classified

111

780

1.43

3.26

1.8

1.7

—

Injury of nerves and spinal cord at thorax level

3.69

3.26

1.3

1.4

—

Otalgia

584

1.50

3.25

1.6

1.7

—

Other specified/unspecified dorsopathies

242

1.80

3.25

1.4

1.6

—

Crushed, pushed or stepped on by crowd or human stampede

370

1.63

3.24

1.2

1.6

—

Other and unspecified disorders of binocular movement

4.31

3.23

1.5

1.6

—

Excessive vomiting in pregnancy

347

1.65

3.23

1.9

1.7

—

Hypothyroidism due to medicaments and other exogenous substances

2.37

3.22

1.3

1.6

—

Vasomotor and allergic rhinitis

333

2665

1.22

3.21

1.6

1.8

—

Cystic disease of liver

2.73

3.20

1.3

1.6

—

Streptococcus and staphylococcus as the cause of diseases classified to other chapters

3.39

3.20

1.1

1.3

—

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

380

1.62

3.19

1.3

1.2

—

Pulmonary oedema

172

1.96

3.18

1.8

1.6

—

Pneumothorax

612

1.48

3.18

1.8

1.6

—

Chronic diseases of tonsils and adenoids

620

4520

0.86

3.18

1.8

—

Salpingitis and oophoritis

173

1313

1.32

3.18

1.4

1.8

—

Impingement syndrome of shoulder

279

2249

1.25

3.17

1.8

—

Haemorrhagic disorder due to circulating anticoagulants

138

2.09

3.17

1.2

1.5

—

Benign neoplasm of urinary organs

452

1.57

3.17

1.2

1.7

—

Malignant neoplasm of nasal cavity and sinuses, including Hilmo

3.02

3.16

2.3

1.3

—

Sequelae of injuries of upper limb

105

736

1.44

3.16

2.2

1.7

—

Oxicams

297

1357

1.25

3.16

1.8

1.6

—

Personal history of risk-factors, not elsewhere classified

2.67

3.16

1.3

—

Carcinoma in situ of skin of lower limb, including hip

238

1.81

3.15

1.8

1.5

—

Livedoid vasculitis

3.38

3.15

1.2

1.8

—

Acute inflammation of orbit

3.54

3.15

2.8

1.2

—

Other keratitis

112

795

1.42

3.14

1.3

1.7

—

Scabies, including avohilmo

111

786

1.42

3.14

1.5

1.7

—

Vascular diseases of the intestine

390

1.61

3.14

1.5

—

Alzheimer’s disease (Early onset)

470

0.48

3.13

1.6

1.4

—

Cluster headache, wide

201

1.86

3.13

1.4

1.8

—

Pediculosis, acariasis and other infestations

374

1.62

3.13

1.6

1.7

—

Glucosamine medication

687

4782

1.15

3.12

1.6

1.7

—

Kidney diseases associated to Fabry's disease

8.09

3.12

2.0

1.5

—

Pemphigus

2.78

3.11

1.3

1.8

—

Scleritis

2.38

3.11

1.5

1.7

—

Ocular pain

590

1.49

3.11

1.4

1.6

—

Episcleritis

344

1.64

3.10

1.2

1.7

—

Other and unspecified pemphigoid

2.34

3.10

1.2

1.7

—

Chorioretinal inflammation

224

1.81

3.10

2.4

1.5

—

Open wound of thorax

2.27

3.09

1.6

1.7

—

Malignant neoplasm of bone and articular cartilage of limbs, including Hilmo

3.25

3.09

3.1

1.3

—

Cystic fibrosis

6.21

3.08

1.0

1.6

—

Malignant neoplasm of tonsil

2.48

3.07

1.9

1.3

—

Other and unspecified papulosquamous disorders

3.00

3.07

1.4

1.3

—

Suppurative and unspecified otitis media

268

1907

1.25

3.07

1.8

1.6

—

Otitis externa, unspecified

110

782

1.42

3.07

1.7

1.6

—

Infectious mononucleosis

246

1.76

3.06

2.1

1.6

—

Infectious mononucleosis, including avohilmo

246

1.76

3.06

2.1

1.6

—

Hypotension due to drugs

133

2.08

3.06

1.6

—

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

323

2655

1.22

3.06

1.7

—

Traumatic subarachnoid haemorrhage

292

1.70

3.06

1.6

1.8

—

Parkinson's disease, strict definition, excluding more controls

166

1175

1.33

3.05

1.3

1.8

—

Malignant neoplasm of nasopharynx, including Hilmo

4.46

3.04

1.2

1.3

—

Injuries involving multiple body regions

255

1.75

3.03

1.7

1.6

—

Parkinson's disease, excluding more controls

176

1240

1.31

3.02

1.3

1.8

—

Dermatographic urticaria

409

1.58

3.02

1.5

1.7

—

Atypical mycobacterium lung infection

107

2.21

3.02

1.4

1.6

—

Other bursitis, not elsewhere classified

2.47

3.01

1.2

1.7

—

Postviral fatigue syndrome

4.37

3.01

1.6

2.0

—

Carcinoma in situ of skin of ear and external auricular canal

162

1.96

3.00

1.6

1.4

—

Abnormal blood-pressure reading, without diagnosis

301

1.68

3.00

1.9

1.7

—

Malignant neoplasm of liver and intrahepatic bile ducts

219

1.80

3.00

1.3

1.2

—

Hypersensitivity angiitis

3.40

2.99

1.8

1.6

—

Other acquired deformities of musculoskeletal system and connective tissue

340

1.64

2.99

1.8

1.7

—

Perichondritis of external ear

148

2.00

2.99

2.5

1.5

—

Perioral dermatitis

127

2.08

2.99

1.1

1.6

—

Malignant neoplasm of oral cavity

212

1.81

2.97

1.1

1.2

—

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

183

1396

1.30

2.97

1.8

1.7

—

Benign neoplasm of major salivary glands

121

881

1.38

2.97

1.5

1.7

—

Primary open-angle glaucoma, strict

394

3305

1.19

2.96

1.6

—

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Immunofixation for Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS